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ABSTRACT OF THE DISSERTATION
Benefits and Barriers to HIV Testing in a Population of Federal Detention Inmates
by
Nicole A. Knight
Doctor of Public Health Candidate in Preventive Care
Loma Linda University, 2014
Susanne Montgomery, MS, MPH, PhD, Chair
Voluntary HIV testing in combination with early medical intervention has been
shown to be effective in reducing the rate of new infections and improving the health and
life expectancy of those living with HIV. There are however several high-risk
populations in the US that remain largely unreached by HIV testing efforts, some of
which could be reached while they spend time in prison or jail. Per current Bureau of
Prisons (BOP) policy, HIV testing is routinely offered only to “high risk” pretrial and
sentenced inmates. We conducted a cross-sectional study with 721 pretrial and sentenced
inmates who entered a large urban federal prison between August 2012 and June 2013.
We explored HIV testing data for the inmates during this period and in addition collected
survey responses from 397 participating inmates. The survey was designed to help us
better understand inmates’ attitudes about HIV testing. Bi-variable and multivariate
analyses were used to determine inmates’ decision to test for HIV. While age, ethnicity,
sentencing status, sexual orientation, and risk status were significantly related with
inmates’ decisions to test for HIV in bivariable analyses, only perceived benefits retained
m
its significance in the multivariable model. It is hoped that findings from this study will
help guide HIV testing policies for federal prisons.
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A. Statement of the Problem
Human immunodeficiency virus (HIV) and acquired immune deficiency
syndrome (AIDS) are major public health issues. As stated in the Executive Summary of
the National HIV/AIDS Strategy for the United States, one American is infected with
HIV every nine and a half minutes (The White House Office of National AIDS Policy,
2010). While overall rates for HIV transmission have decreased and for those infected,
HIV has become a chronic disease. People with HIV are living longer and more
productive lives. There are over 1 million people who are infected with the virus and it is
estimated among these at least 21% are unaware of their HIV status (Centers for Disease
Control & Prevention [CDC], 2010).
In July 2010, President Obama executed a National HIV/AIDS Strategy for the
United States. The three primary goals for the strategy include: (a) reducing the number
of people who become infected with HIV; (b) increasing access to care and optimizing
health outcomes for people living with HIV; and (c) reducing HIV-related health
disparities (Office of National AIDS Policy, 2010). The President is calling on broad
support that includes the Federal Government, state, tribal and local governments, faith
communities, scientific and medical communities, and educational institutions to
implement multiple strategies to help meet these goals.
In the United States, there are approximately 2 million people who are
incarcerated in either state or federal prison. By adding those on either probation or
parole the number of people affiliated with the prison system is tripled (Maruschak &
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Beavers, 2009). According to internal prison data, the number of inmates currently
housed in federal prison is approximately 217,000 (Federal Bureau of Prisons Weekly
Population Report, 2012). Many of the individuals who enter the prison system have a
history of risk behaviors such as unprotected sex, multiple sexual partners, intravenous
drug (IV) use, tattooing, etc., which in turn puts them at increased risk for HIV/AIDS
(Altice, et al., 2005). As a result, and based on the fact that many of these high risk
behaviors continue to occur in prison although they are prohibited the rates of HIV/AIDS
are increasing in the prison population.
According to the Bureau of Justice Statistics, in 2008 there were a reported
21,987 inmates in state or federal prison who were infected with HIV or AIDS. This
accounts for approximately 1.5% of the total custody population. At the end of 2008,
1.5% of the male prison population (20,075) and 1.9% of the female prison population
(1,912) were infected with HIV/AIDS (Maruschak & Beavers, 2009). Clinical studies
(Andrinopoulos, Kerrigan, Figueroa, Reese, & Ellen, 2010) as well as pilot studies
(Beckwith et al., 2010) point to the urgent need for early HIV testing in prison
populations in order to identify undiagnosed HIV infection to facilitate early treatment of
those yet to be diagnosed and implement preventive education and treatment to limit
further spread.
In 2006, the CDC recommended that correctional facilities perform HIV testing as
part of a routine medical evaluation. In a study regarding HIV testing in emergency room
departments, the Director of the Centers for Disease Control Division of HIV/AIDS
Prevention, Jonathan Mermin, MD stated, “Ensuring that all Americans know their HIV
status is vital to ending the U.S. HIV epidemic” (Centers for Disease Control, 2011, p.l).
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Clearly, the federal prison system with its many individuals at higher risk for
potential HIV infection is in a position to help reduce new HIV infections by developing,
evaluating, and implementing effective preventive strategies such as early HIV testing
and prevention education. Early detection of HIV/AIDS is important for optimal
treatment, prevention of complications, decreasing transmission of HIV, and improving
the health of those living with HIV.
In 2008, the Federal Bureau of Prisons (BOP) adopted the CDC’s testing
recommendations to include offering voluntary HIV testing of individuals convicted of a
Federal offense who are sentenced to a period of six months or more. Additional
requirements included assessing an inmate’s risk factors and screening for HIV during
initial entry and throughout their incarceration period. The BOP Clinical Practice
Guidelines on HIV and Preventive Health currently state that voluntary screening for
HIV infection is to be conducted at intake or during initial physical examination, which is
completed within 14 days of admission for all inmates who have any of the following:
• Signs/symptoms of acute HIV infection or HIV-related condition
• Pregnancy
• Recent exposure or victim of a sexual assault
• Active tuberculosis (TB) or a positive TB skin test or,
• When otherwise clinically indicated (i.e. risky sexual behavior, IV drug
use, sexually transmitted disease (STDs), exposure-related, etc. (Federal
Bureau of Prisons, 2009).
In January of 2012, internal prison data indicated that there were approximately
216,613 sentenced inmates in the BOP, who are primarily housed at Federal Correctional
3
Institutions, Federal Correctional Complexes, BOP private jails, and BOP contract
facilities, including home confinement. However, administrative facilities such as
Federal Detention Centers within the BOP also currently house sentenced and
unsentenced (pretrial) inmates. Since current guidelines suggest testing only for
sentenced inmates, approximately 11,000 pretrial (not yet sentenced) inmates in the BOP
are not routinely tested for HIV unless they meet the criteria as stated in the Clinical
Practice Guidelines. More specific to this proposal, there are approximately 1,031
inmates housed at the Metropolitan Detention Center in Los Angeles; of these,
approximately 800 are pretrial. Retrospective studies revealed that a significant number
of HIV cases could have been identified if HIV testing was done during a prior arrest
(Duffiis, et ah, 2009).
In 2009, the Rhode Island Department of Corrections (RIDOC) evaluated their
HIV testing program to determine HIV case identification, HIV risk factors, and the
approximate number of inmates (detainees) who may have not been tested early in their
incarceration. The study revealed that if HIV testing was delayed, 43% (72) of detainees
would have been released prior to being tested. This may have led to a delay in the
diagnosis and treatment of HIV, increased the risk of transmission, and missed
opportunities for HIV prevention education (Andrinopoulos, et al., 2010). Moreover,
Kavaser et al. (2009) found that rates of HIV testing are higher when offered early in the
incarceration.
Basu, Smith-Rohrberg, Hanck, & Altice (2005) recommend that HIV testing be
offered to all inmates, both sentenced and those awaiting sentencing, regardless of risk
factors. This, they believe, is the best testing strategy in correctional institutions to detect
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HIV early enough to prevent infection, control transmission, and improve the health of
those with HIV. A hypothesis offered herein is that a higher than currently known HIV
rate will be identified when HIV testing is offered to all inmates, rather than when offered
only to sentenced inmates and unsentenced high-risk inmates. If true, this hypothesis
would open a major window for early intervention and unique preventive opportunities.
HIV/AIDS is a serious and stigmatized disease that is laden with a number of
barriers to testing. Many may be afraid of finding out that they are HIV positive, and
therefore avoid getting screened. Others fear stigma or being segregated from the general
prison population. Therefore, it is important for the provider to create an environment
that stresses confidentiality and explains the benefits of HIV testing. To further facilitate
voluntary testing, it is important to learn more about barriers to HIV testing, so that
programs can be developed to help address them.
Providing inmates with information about the benefits of HIV testing, such as
early detection of the disease, reduced transmission, and prolonging one’s quality of life
may reduce barriers to testing. Understanding the benefits or importance of HIV
counseling and testing is essential for early HIV/AIDS detection to facilitate optimal
treatment, prevent complications, decrease transmission, improve the health of positive
individuals, and most important, increase willingness to test. It is important to evaluate
inmates’ understanding of the benefits of testing and to educate them about the benefits
before they make the decision whether or not to test. This study is designed to explore
perceived benefits and barriers to HIV testing in inmates housed at the Federal Detention
Center in Los Angeles, and how this impacts their decision to get tested for HIV if
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offered to them. To do this we used the Health Belief Model to better understand the
decision making process.
The Health Belief Model (HBM) is a theoretical framework, which is used to
explain and predict health behaviors (Zak-Place & Stem, 2004). The model examines an
individual’s perception about a preventive health action, and uses the concepts of
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues
to action, and self-efficacy to better understand the factors that influence health decisions
— in this case, testing for HIV. Elements of the HBM were used in our study to assist in a
better understanding of the inmate’s decision-making processes about voluntary HIV
testing.
B. Purpose of the Study
In order to facilitate early detection of HIV to prevent, control transmission, and
improve the health of individuals with HIV, it is recommended that HIV testing be
offered to all inmates, including those who are considered high-risk and low-risk for
HIV. The purpose of this study is twofold: 1. to study the decision-making process
about HIV testing in inmates, and ultimately to increase HIV testing, which in turn will
lead to the early diagnosis of HIV in inmates of the Federal Detention Center; and 2. to
determine if BOP policy of targeted testing is sufficient in identifying HIV positive
patients. Increased incidence of HIV seropositivity in Federal Detention Centers may
indicate the need to revise the current policy regarding HIV testing to include voluntary
HIV testing among all inmates housed in Federal Detention Centers. To best accomplish
this we applied selected concepts of the HBM to explore inmates’ perceptions of HIV
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severity and susceptibility, while identifying barriers and understanding the benefits to
HIV testing, which the BOP can also utilize to promote HIV testing.
C. Research Questions
This cross-sectional study was conducted in the Federal Bureau of Prisons at the
Metropolitan Detention Center in Los Angeles, California. For a period of approximately
12 months we offered HIV testing to all male inmates, rather than only to select inmates,
as is current practice, allowing us to examine the resulting rates of HIV testing. In
addition to explore inmates’ attitudes about the barriers and benefits to HIV testing, we
invited all inmates, sentenced or pre-trial, to complete a short survey that included
demographic questions and questions related to some of HBM constructs. Our research
questions were as follows:
What are rates of HIV testing in an inmate population housed in a Federal1.
Detention Center that offers HIV testing to all inmates as part of its medical
intake procedures?
Does the rate of voluntary HIV testing differ between unsentenced (pretrial) low2.
risk inmates and unsentenced (pretrial) high-risk inmates?
What are the perceived severity and susceptibility of HIV, and the perceived3.
benefits and barriers to HIV testing in this Federal Detention Center population?
What are the rates of HIV seropositivity among a population of inmates housed at4.
a Federal Detention Center that is tested for HIV?
Does the rate of HIV seropositivity differ between unsentenced (pretrial) low-risk5.
inmates and unsentenced high-risk inmates?
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D. Significance to Preventive Care
Increasing the proportion of adults and adolescents who have been tested for HIV
in the past 12 months is one of the Department of Health and Human Services’ Healthy
People 2010 Objectives (Healthy People 2010). A review of literature on HIV testing
revealed that the federal prison system is lacking in research and/or studies regarding
HIV testing. Many argue that broad-based testing in prisons should take place given the
target population and continued risk behaviors. This study identified the prevalence of
HIV seropositivity among those who volunteered to be tested in an urban Federal
Detention Center. Since the prevalence of seropositivity is in pre-trial inmates was
significant, the BOP may need to re-evaluate current policies and guidelines regarding
HIV testing, and offer HIV testing to all inmates to increase early detection of HIV.
Simply acknowledging a need to increase testing in detention centers is a
necessary first step, but not sufficient. We plan to present the HIV testing results of our
study to preventive care specialists who provide care to adults in the prison population.
Using a HBM driven survey, we evaluated the psychosocial constructs important to
understanding inmates’ concerns, needs, and readiness around testing. With this
information, preventive care specialists involved in inmate health care delivery can now
gain better awareness about the meaning, complexity, and fears of HIV testing among the
inmates they serve. We hope that our results will then also be applied to the care of
inmates to increase voluntary HIV testing in a high-risk population in need of early
intervention. Furthermore, for those inmates who test sero-negative for HIV, it would
likely provide an opportunity for education and counseling about risky behaviors, and for





Infection with the human immunodeficiency vims (HIV) leads to acquired
immune deficiency syndrome (AIDS) if the vims is not diagnosed early or left untreated.
HIV is spread primarily through high-risk behaviors such as unprotected sexual
intercourse, intravenous dmg use, unregulated tattooing, etc. In the interest of better
disease prevention for all, Altice et al. (2005) suggests that current voluntary HIV testing
and counseling has not been effective in reaching groups at high risk for the vims, which
hinders efforts to decrease HIV prevalence. To reach these groups, e.g. men who have
sex with men, IV dmg users, prisoners, gays, etc., use of saliva vs. blood tests, rapid
serologic tests, and more routine testing in high risk and prevalence areas such as
correctional settings is recommended. Many individuals who enter the federal prison
system have a history of high-risk behaviors (Altice, et al., 2005).
Of particular concern is the increase of HIV/AIDS among inmates confined in
state and federal prisons. In 2008, according to the Bureau of Justice Statistics, 21,987
inmates in state or federal prison were reportedly infected with HIV. By the end of 2008,
there were approximately 4,561 inmates in state custody and 613 inmates in federal
custody who were not only HIV seropositive but whose disease had progressed to AIDS
(Mamschak & Beavers, 2009). This accounted for 0.5% of inmates in state prison and
0.3% of inmates housed in federal prison. Nevertheless, nearly 24% of inmates in state
and federal prison had confirmed AIDS by the end of 2008 (Mamschak & Beavers,
2009).
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Early voluntary HIV testing of the incarcerated is recommended for the early
detection, prevention, control of transmission, and improved health of inmates. Studies
have shown that when HIV testing was not performed during an early incarceration
period, several cases of inmates who presented with a history of HIV were not diagnosed
(Andrinopoulos, et ah, 2010; Duffus et ah, 2009). While HIV testing is encouraged as a
strategy for the early identification of the disease, health practitioners and BOP staff need
to better understand the potential benefits and barriers to testing from an inmate’s
standpoint.
The purpose of this section is to review the literature and discuss current HIV
testing strategies in correctional settings as well as the benefits and barriers to testing.
Due to the limited number of studies in Federal prisons, studies examining similar
populations including state and county jails will be examined to explore the relevance of
HIV testing, perceived benefits, and barriers of HIV testing in Federal Detention Centers.
To help guide our inquiry from a theoretical perspective, the HBM will be used to guide
our exploration into factors influencing inmates’ decisions for HIV testing.
B. HIV/AIDS Prevalence in Prison
People who are incarcerated in prison in the United States have higher rates of
health problems and chronic diseases when compared to the general population
(Goldenson & Hennessey, 2009). The prison population also has a disproportionate
burden of infectious disease, including HIV (Spaulding et ah, 2002). From 1999 to 2006,
“the prevalence of confirmed AIDS among the prison population was between 2.7 and
4.8 times higher than in the general US population” (CDC, 2009, p. 6). According to the
Centers for Disease Control and Prevention (CDC) a conservative estimate of the
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prevalence of HIV among the incarcerated is almost five times greater (2.0%) when
compared to the general population (0.43%) (CDC, 2006). These trends were also
confirmed by Wohl, Rosen, & Kaplan (2006).
A disproportionate number of the incarcerated are from low-income backgrounds
and racial and ethnic minority groups (Braithwaite & Arriola, 2003; Goldenson &
Hennessey, 2009). In the mid 2000’s, 12% of black men in their 20s and 30s had been
incarcerated, compared to 1.7% of white men with similar ages (Spaulding, et ah, 2002).
Furthermore, many previously incarcerated individuals tend to lead lifestyles that at one
time or another included HIV risk: a history of substance abuse, poverty, homelessness,
unsafe sexual practices, and mental illness (Rapposelli et ah, 2002).
In 2006, there was an estimated 17% of Americans who had at some time in their
life entered the prison system, and 1 in 7 of whom were infected with HIV (Wakeman &
Rich, 2010). In mid-2007, the CDC reported rates of incarceration among the different
ethnic groups. The percentage of inmates in either state or federal custody who are black
was 35.4%; 17.9% were Hispanic (CDC, 2009). In addition, 22-28% of black men who
were infected with HIV during 2006 had been incarcerated at some point in their lives
(Wakeman & Rich, 2010).
C. Risk Factors for HIV/AIDS in Prison
As noted earlier, many individuals who enter the prison system have a history of
behaviors, which increase their risk of contracting HIV. For example, studies have
shown that 25-40% of males who enter the prison system have a history of IV drug use,
as compared to 0.6% of the general population (Vlahov & Putnam, 2006).
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This may be related in part to the 1988 Anti-Drug Abuse Act, which created
mandatory minimum sentences for crimes involving the manufacturing, distribution, and
use of illegal drugs, and use for other purposes resulting in a significant increase in
prisoners who committed a drug and/or sex related offense (Sylla, Harawa, & Grinstead
Reznick, 2010). Since many of these prisoners engaged in high-risk behaviors before
their incarceration, the number of prisoners participating in high risk behaviors while
incarcerated also increased (Sylla, et ah, 2010).
Although sexual contact, substance abuse, and tattooing are prohibited in
correctional facilities, these practices continue. In a survey conducted in a Tennessee
state prison, 12% of the inmates reported that they have injected drugs during their
incarceration (Vlahov & Putnam, 2006). Yet in another prison survey, reports of
homosexual practices while incarcerated were self-reported at 33% (Vlahov & Putnam,
2006). Some of these risky behaviors include intravenous drug use, tattooing, multiple
sexual partners, unprotected sex, etc., all of which are also HIV risk behaviors.
Furthermore, the frequency of risky behaviors often increased in prison due to boredom,
untreated addictions, unavailability of condoms, and lack of access to clean syringes and
tattooing needles (Hellard & Aitken, 2004).
Several studies (Hammett, 2006; Seal, Eldridge, Zack, & Sosman, 2010) have
shown that prisoners engage in sexual and drug related high-risk behaviors. In 2008, Seal
et al. conducted a study that examined the substance use and sexual behavior of men
between the ages of 18 and 29 years while incarcerated. The results of the study revealed
that 50% of the men had used substances and 17% engaged in sex during their
incarceration (Seal et al., 2008).
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While it is generally acknowledged that transmission of HIV while in prison is
not uncommon, there are few studies describing the prevalence of intraprison
transmission. In an assessment by Krebs and Simmons (2002), 33 new cases of HIV
among inmates in state prison were identified. Similarly, Altice et al., (2005) identified
the relationship between seroprevalence and HIV risk behaviors among females in an
anonymous but linked HIV serosurvey. The researchers found that of 3315 participants,
7.5% (250) were HIV positive, but of these only 63% (157) had reported being HIV
positive prior to testing. The highest HIV risk behaviors reported was having sex with a
known HIV infected individual and IV drug use.
The above-mentioned studies have discussed risk factors associated with HIV. In
addition, risk factors specific to the higher rates of HIV in prison populations were
identified. That these risky behaviors occur and are even heightened in prison reveals the
importance of HIV testing, which increases early identification and improves treatment
options of those infected with the virus.
D. HIV Testing in Prison
Early diagnosis of HIV is vital to improving the quality of life of those infected
and decreasing the transmission of HIV. Populations more likely to be incarcerated are
among those historically more difficult to access with prevention efforts. This is often
attributed to prisoners’ limited access to healthcare prior to incarceration. Hence, periods
of incarceration provide an opportunity for HIV testing, diagnosis, and treatment of a
high-risk population.
If HIV testing is not offered to all inmates while incarcerated, cases of HIV may
not be detected and properly diagnosed. Studies have shown that when HIV testing is
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offered only to inmates with a history of high-risk behaviors, inmates reporting behaviors
which are considered low-risk, such as engaging solely in heterosexual sex, are less likely
to be tested for HIV (Rosen et ah, 2009). In their study, Rosen et al. (2009) examined
voluntary HIV testing among prisoners in the North Carolina state prison system. Of
54,016 inmates entering the system from January 2004 through May 2006, 38% (20,820)
were tested for HIV, with most testing (89%) taking place at intake. Inmates with high-
risk behaviors were at least 10% more likely to be tested, while 60% of those reporting
low-risk behaviors were not tested (Rosen, et al., 2009). In addition, black men were
30% less likely to be tested for HIV than white men, and many whose behavioral profiles
would label them, as “high-risk” were never tested. The study revealed the importance of
offering HIV testing to all inmates upon intake to increase early detection of HIV,
especially among high-risk and minority populations.
The Maryland Division of Corrections offers HIV testing to all inmates upon
entry, in addition to testing when clinically indicated. Kassier et al. (2001) conducted a
review of the Maryland Division of Corrections current HIV testing guidelines. The HIV
seropositivity in 1998 was 3.3%, revealing the importance of HIV testing, treatment, and
prevention strategies to identify new cases of HIV in prison settings, not only among
those who report high risk behaviors, but to the entire inmate population (Kassira et al.,
2001).
Studies have shown an increase in the rates of HIV seroprevalence among inmates
engaging in high-risk behaviors. Sexually transmitted infections and the prevalence of
HIV among men incarcerated at the Los Angeles County Men’s jail between March 2000
to December 2005 was evaluated by Javanbakht et al. (2009). The study conducted
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voluntary HIV screening on the segregated men who have sex with men unit. The
study’s population included a total of 7004 inmates from March 2000 through December
2005. The prevalence of HIV in this population was 13.4% (625 out of 4658), with the
screening continuing over a five-year period. Approximately 15% of the inmates
reentered the jail and had repeat HIV testing. Of these, 15% (33 inmates) were newly
diagnosed with HIV when repeat testing was done, resulting in a HIV incidence of 1.9%
(Javanbakht, et al., 2009).
Duffus et al. (2009), conducted a retrospective population-based cohort study
comparing case reports from HIV/AIDS Reporting System (HARS) and the South
Carolina Law Enforcement Division database to determine if HIV/AIDS cases could
have been diagnosed during a prior arrest. The study revealed that 48.6% (1961/4036) of
those diagnosed with HIV had at least one prior arrest before they first tested positive for
HIV (Duffus, et al., 2009). It was revealed that 65.6% (1286/1961) were probably HIV
positive at the time of their prior arrest. Of those who tested positive, 46% (694) did not
develop AIDS within one year of testing, indicating that they were diagnosed relatively
soon after contracting the virus. However, 54% (694) developed AIDS within one year
of testing, indicating that they were tested late for HIV, resulting in significant health
deterioration after the missed opportunity for intervention.
A blinded serosurvey was conducted to determine the prevalence of HIV among a
city jail in New York, which showed that 68.9% (6411) of prisoners who entered the jail
were tested for HIV and 5.2% were diagnosed with the virus. Of this group, 28.1% were
newly diagnosed. In addition, only 11.5% were diagnosed during the testing of self-
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identified high risk individuals, thus potentially missing at least 16.6% of infected
inmates (Begier et ah, 2010).
A prospective controlled trial in an urban men’s jail in New Haven, Connecticut
was conducted to assess the ideal time in which opt-out HIV testing should be routinely
offered to newly incarcerated inmates (Kavasery, Mam, Sylla, Smith, & Altice, 2009);
the primary objective was to increase the rates of men who consent to testing. Two
hundred and ninety-eight participants were offered routine opt-out HIV testing on the day
of incarceration, the next day, or 7 days after incarceration. The researchers found that
53% of the participants who were offered HIV testing on the same day of their
incarceration consented, compared to 45% who were offered testing the next day, and
33% who were offered testing 7 days after incarceration (Kavasery, Mam, Sylla, et al.,
2009). Thus, routine opt-out HIV testing produced higher rates of testing when offered
within the first 24 hours of incarceration.
Similarly, in Kavasery et al.’s (2009) prospective controlled trial of routine opt-
out HIV testing among 323 newly incarcerated females in a Connecticut jail, 55% of the
women who were offered HIV testing on the day of incarceration consented, compared to
73% who consented on the next day, and 50% who consented to testing 7 days after
incarceration (Kavasery et al., 2009). In this case, testing rates were highest when
offered the day after incarceration. All reviewed studies point to the unique opportunity
prisons have to access and provide HIV testing to hard to reach, high-risk populations,
thus identifying undiagnosed HIV infections and facilitating early treatment.
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E. Barriers to HIV Testing
The health belief model (HBM) is a conceptual framework which incorporates the
concepts of perceived susceptibility, perceived severity, perceived benefits, perceived
barriers, cues to action, and self-efficacy to explain and predict health behaviors (Zak-
Place & Stem, 2004). The model stipulates that a person’s intention to engage in
preventive health action are influenced by their assessment of perceived benefits and
barriers to engaging in the behavior - in this case, HIV testing. We will therefore apply
variables from the HBM in our study to better understand inmates’ decision-making
processes about HIV testing.
While no such study has been conducted in the prison system there are few from
other settings. Lyons, Lindsell, Fichtenbaum, & Camargo (2007) conducted a review
which interpreted and implemented the 2006 CDC recommendations for HIV testing in
health care settings. The researchers found that perceived barriers to testing included fear
of being stigmatized or discriminated against, being segregated, and stereotyping.
Riley & Baah-Odoom (2010) examined the perceived barriers of stigma, blame,
and stereotyping. Blaming and stereotyping specific to HIV/AIDS as a disease, which is
primarily spread through sexual contact, made the individual feel at greater risk for such
discrimination. Therefore, the individual reported that they were more likely to engage in
safer sexual practices rather than risk contracting the disease and the resulting
stigmatization (Riley & Baah-Odoom, 2010). When a prisoner enters the correctional
environment, lack of tmst may keep them from disclosing to staff their medical or high-
risk behavior history for fear that it will not be kept confidential. Though it is important
to maintain HIV confidentiality in all settings, it is especially critical in a prison setting
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(Wakeman & Rich, 2010), where a breach in confidentiality could lead to stigmatization
or even create a potential for inmate violence. Routine rapid HIV testing of all inmates in
correctional settings is one method of reducing stigmatization (Wakeman & Rich, 2010).
Another barrier to HIV testing is the perception that a prisoner’s past behavior
will have a bearing on their current criminal charges. Upon entry to the correctional
setting, reporting behaviors such as IV drug use or multiple sexual partners may make the
prisoner feel that this could affect the criminal charges they are facing, as reported by
Spaulding, Arriola, Hammett, Kennedy, & Tinsley, (2009). As a result, inmates may not
accurately report their history and thus may not be offered HIV testing. Again, making
this mandatory for all inmates might mitigate such fears and result in better disclosure or
at least identification of HIV, regardless of potentially questionable self-reporting.
The relationship between self-efficacy in coping with HIV, HIV related stigma,
and acceptance of HIV testing was examined among incarcerated men in the Jamaican
prison system (Andrinopoulos, et ah, 2010). The study participants, a sample of 298
randomly selected men, completed a cross-sectional quantitative survey. The prisoners
who were more likely to agree to test for HIV included those who reported a high HIV
coping self-efficacy, some perceived risk of HIV, and low perceived HIV testing stigma.
Barriers that influenced testing were related to self-efficacy, including external and
internal HIV stigma, lack of a social support system, and lack of knowledge about the
disease (Andrinopoulos, et ah, 2010). The study demonstrated that HIV stigma is a
barrier that can influence testing.
In addition to these perceived prisoner-related barriers that may discourage
testing, there are also provider-related barriers that can limit testing. Sabharwal et al.
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(2010) conducted a survey which examined provider-related barriers to testing. Some of
the most common challenges that resulted in limitations on testing included staffing
shortages, lack of privacy or space, and excessive paperwork. In addition, some of the
barriers reported by providers working in correctional settings included insufficient time
for intake screening, while also trying to complete other responsibilities specific to
correctional settings (Sabharwal, et al., 2010).
F. Benefits to HIV Testing
It has been estimated that approximately 21% of the US population are unaware
of their HIV status (CDC, 2010; Mahoney, Fogler, Weber, & Goldschmidt, 2009). Early
diagnosis of HIV is important since early treatment increases optimal outcomes and for
preventing further spread of the disease. If HIV testing is increased to include a greater
number of prisoners, inmates could be identified earlier, receive timely and appropriate
medical care, and get the necessary treatment to prevent clinical progression and
transmission (Mahoney, Fogler, Weber, & Goldschmidt, 2009).
Studies have shown (Maruschak as cited in Rapposelli et al., 2002) that AIDS-
related deaths have decreased from 33% in HIV positive inmates in 1995 to slightly over
8% in 2000. This is a direct result of both federal and state prison systems providing
early initiation of highly active antiretroviral therapy to inmates infected with the disease.
The CDC’s Initiative on Advancing HIV Prevention organized a demonstration
project, which was aimed at increasing routine rapid HIV testing in short-stay
correctional facilities. The project revealed that 39% of the 269 newly identified
prisoners who tested positive were those who most commonly reported engaging in
unprotected heterosexual intercourse (Spaulding, Arriola, Hammett, Kennedy, & Tinsley,
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2009). If testing was done only on prisoners with traditionally identified HIV high-risk
behaviors (IV drug use, multiple sexual partners, etc.), these 269 individuals may have
not been tested and properly diagnosed, revealing the importance of HIV testing for all
inmates regardless of “low-risk” reported behaviors.
In 2006-2007, a pilot study was conducted at the Rhode Island Department of
Corrections central jail to determine the benefits of different HIV counseling and testing
methods (rapid vs. delayed results) among those with risky behaviors who tested negative
for HIV. Risk behaviors were assessed among 264 newly incarcerated inmates at
baseline and six weeks after being released from jail (Beckwith, et ah, 2010). One
hundred thirty-two of the participants received standard HIV counseling and testing and
individualized counseling sessions. Fifty-nine percent of the participants completed the
follow-up. All participants who received the rapid HIV testing received their results,
whereas only 28% of those using conventional testing received their results due to the
participant being released from the jail. The study revealed the importance of offering
HIV rapid testing to increase follow-up for test result as well as awareness of HIV status
and decrease at risk behaviors (Beckwith, et al., 2010).
As part of a study about the prevalence and correlation of high-risk behaviors on
rates of HIV, hepatitis B, and hepatitis C among inmates in an Indonesian prison (Nelwan
et al., 2010), researchers examined voluntary counseling and testing of prisoners, and
access to HIV treatment upon entry to prison. Of the 639 inmates, 7.2% were HIV
positive and 68% of these were treated during their prison stay. The study revealed the
importance of HIV testing among inmates upon initial entry into the prison system to
increase the detection and improve treatment options of HIV positive inmates.
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G. Strategies in Correctional Setting to Improve HIV Testing
Many incarcerated individuals have had limited access to health care prior to their
arrest. This may have been due to homelessness, lack of insurance, or prevention or
medical care being seen as a lesser priority. When these prisoners enter jail, it is often
their first introduction to the health care system since childhood (Goldenson &
Hennessey, 2009). This makes it possible for prison systems to diagnose, treat, manage,
and prevent the spread of different preventable and infectious diseases such as HIV,
which has an impact on the health of the nation as a whole. If individuals with HIV are
not identified and treated while within the correctional system, they are likely to re-enter
the community (Shiraldi as cited in Rapposelli et ah, 2002) and possibly add to incidence
of the disease.
Traditionally, correctional institutions tend to concentrate HIV testing on
prisoners with high-risk behavior i.e. a history of IV drug use, multiple sexual partners,
sexually transmitted diseases, etc. As a result, more than one in three prisoners are never
tested (Wakeman & Rich, 2010). The Bureau of Justice Statistics reported that in 2006,
less than half of state prisons tested all inmates for HIV, whether it be upon admission,
while in custody, or prior to release (Federal Bureau of Prisons, 2009). In addition, 45
states and the Federal Bureau of Prisons reported testing only if the inmates had HIV-
related symptoms.
There are different types of HIV testing methods: mandatory, voluntary (opt-in),
and routine opt-out (option to decline) testing. Some have proven to be more effective in
different settings. Current HIV testing strategies in correctional institutions were
examined to determine the most effective strategy. Basu et al. (2005) concluded that
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mandatory testing was the most preferred testing method for those incarcerated. They
also recommended establishing policies for continued counseling and follow-up of those
identified as HIV positive once they are released back into the community.
A routine, voluntary HIV testing program was evaluated in a Massachusetts
county prison (Liddicoat et al., 2006). HIV testing was offered to all sentenced inmates
upon entry to the prison. In this program, the number of inmates who were tested
increased when compared to their previous testing method, which involved testing only
upon inmate or physician request. There was a 73% (734/1004) HIV testing acceptance
rate. Even though the testing rate increased with this routine voluntary method, there are
other recommended methods to increase testing in correctional facilities.
In the 2009 HIV Testing Implementation Guidance for Correctional Settings, the
CDC has recommended routine opt-out HIV screening to all jail inmates upon intake as
the most comprehensive HIV testing strategy. In addition, it was recommended that the
medical staff of the correctional facility should be included in the decisions of when and
how to test for HIV within the institution (Federal Bureau of Prisons, 2009).
Rapid HIV testing is another recommended strategy for correctional settings.
Studies (Macgowan et al., 2009) have shown that rapid HIV testing in jails has identified
a significant number of previously undiagnosed individuals testing positive for the virus.
Macgown et al. (2009) conducted a study with four state health departments and area jails
in Florida, Louisiana, New York, and Wisconsin from December 2003 to May 2006. In
the study period, rapid HIV testing was done on 33,211 inmates; of these, 409 (1.2%)
tested positive, 269 (0.8%) of which were new or previously undiagnosed (Macgowan, et
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al., 2009). Of particular interest, 40% of the newly diagnosed HIV cases were inmates
who had only reported a history of heterosexual contact.
Although several different HIV testing strategies have been studied and discussed,
our study will examine voluntary opt-out HIV testing, using HBM constructs, to all
inmates entering the Metropolitan Detention Center in Los Angeles. This is believed to
improve the detection and early diagnosis of HIV among inmates as well as better
connect them to needed services. It could also prevent infection through the counseling
of individuals testing negative and treatment of those testing positive, resulting in
improved health and significantly reduced health care costs within and without the prison
system.
H. Conclusions
Inmate contact with the prison health care system provides a unique opportunity
for public health officials and preventive care specialists to offer HIV testing to a high
risk, hard to reach population. HIV testing within our prisons and jails is important, since
undiagnosed HIV affects both the individual and the community they return to after
incarceration.
It is estimated that approximately 60% of pretrial inmates in the BOP are not
sentenced and not routinely offered voluntary HIV testing unless they meet the criteria as
stated in the BOP’s Clinical Practice Guidelines. One of the 2020 Healthy People
Objectives is to increase the proportion of adults who have been tested for HIV in the
past year. Our study aims to addresses this need in a particularly vulnerable and high-risk
population, thus helping to reduce the burden of the disease among federally incarcerated
inmates.
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A review of the literature on HIV testing revealed that the Federal Bureau of
Prisons has not conducted research regarding strategies to prevent and reduce HIV among
inmates. With an environment different than those of most studies (i.e. state and county
jails), there is a need for the BOP to conduct studies about the feasibility and need for
HIV testing among those incarcerated in the federal system. Our study provided
important information to help BOP administration to re-evaluate current policies and
guidelines, as well as explore the perceived benefits and barriers to HIV testing for HIV
positive inmates housed at the Federal Detention Center, where the research was
conducted.
The resulting information of our study can increase the ability of preventive care





A cross-sectional mixed method study was conducted in the Federal Bureau of
Prisons at a large urban detention center in accordance with the protection of human
subject research guidelines at the Federal Bureau of Prisons and Loma Linda University;
the target population was males incarcerated at this detention center. In Phase one, the
qualitative phase, key informant interviews were conducted with randomly selected
inmates and prison health care professionals. In the second quantitative phase, all pretrial
and sentenced who entered the detention center between August 2012 and June 2013
were offered voluntary anonymous testing and invited to complete a brief cross-sectional
survey.
B. Participants
Phase one participants included key informants that consisted of three sentenced
inmates and four prison health care professionals.
Participants for phase two included all male inmates, both pre-trial and sentenced,
who entered the federal detention center between August 2012 and June 2013. Although
the detention center houses both male and female inmates, male inmates were selected
since the majority of the population at MDC-LA is male and the prevalence of HIV
positive rates is higher in males than females. Hence, the sample would be more
representative of an HIV positive prison population.
Participants included 721 male inmates between the age of 20 and 80 years.
Unsentenced high-risk and low-risk inmates, who would not routinely be offered HIV
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testing, were compared to the sentenced high and low-risk inmates who would usually be
offered HIV testing. Participants were recruited during their initial admission to
incarceration and recruitment for the two groups ceased once sufficient numbers were
recruited.
C. Data Collection and Procedures
1. Training and IRB Preparation of Data Collection Staff:
Medical staff from the detention center was selected to participate in key
informant interviews, the development of the survey instrument, or questionnaire, and the
administration of the questionnaire to the inmate population. The medical staff consisted
of a health services administrator, assistant health services administrator, dentist,
pharmacist, physicians, mid-level providers, registered nurses, infectious
disease/improving operations program coordinator, dental assistant, pharmacist assistant,
medication technician, medical secretary, and medical records technician. In addition to a
training session that clearly outlined study procedures, all medical staff involved in
administering the questionnaire completed the protection of human subjects trained
offered online by the National Institutes of Health (NIH) prior to administering the
questionnaire.
2. Phase 1 - Qualitative Procedures:
Seven key informant interviews were conducted. The key informants
consisted of 4 medical staff members, who were providing health care services to the
inmate population at MDC-LA and knowledgeable about inmate HIV risk behaviors.
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Three sentenced inmates who agreed to a semi structured interview were selected for the
key informant interviews.
a. Recruitment and Sampling: A systematic convenience sample from
the Health Services Department at MDC-LA was taken to recruit participants for the key
informant interviews; a convenience sample also was taken to recruit from the sentenced
inmate population. Staff participants were eligible if they had some knowledge and
experience regarding voluntary HIV testing and HIV risk behaviors in the inmate
population.
b. Mixed Method Key Informant Interviews: Upon recruitment, key
informants completed a questionnaire which was made up of three questions using a 5-
point Likert-type scale (strongly agree to strongly disagree), as well as three open ended
questions with probes (adapted from the Health Belief Model, which was used as a
theoretical framework). The questionnaire was used to explore issues regarding inmates’
decision making about HIV testing, i.e., their opinion regarding the likelihood of inmates
to volunteer for HIV testing when offered during intake screening. In addition, the key
informants were interviewed in an open-ended fashion using a semi-structured key
informant outline that explored the inmate’s perceived benefits and barriers to HIV
testing.
Key informant interviews were conducted on a one on one basis with both staff
and inmate key informants, the staff interviews done in person or over the telephone, and
the inmate interviews done in person. Written informed consent was obtained from both
staff and inmate key informants. The researcher conducted the key informant interviews
and each lasted for no more than 30 minutes. The purpose of the staff interviews was to
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obtain the perspective of persons who are knowledgeable and experienced with working
and providing health care, including HIV testing, to the inmate population; the inmate
interviews were conducted to obtain the inmates’ perspective. Data obtained from the
key informant interviews was used in the development of the questionnaire, which was
administered to the inmates in Phase 2 of the study.
c. Instrument Development’. Information from the key informant
interviews was used to develop the questionnaire that was administered to the inmate
population entering the facility between August 2012 and June 2013. Subsequent to
revisions, the questionnaire was submitted to the LLU and BOP ERB’s for review and
approval prior to being administered to the inmate population. Once approved by the
IRB, the survey was pilot tested in a small (N^S) group of inmate volunteers. Written,
informed consent was obtained and the inmates were encouraged to give feedback for
improvement of the questionnaire.
3. Phase 2 - Quantitative Procedures:
a. Study Procedures: Male inmates admitted to the detention center
between August 2012 and June 2013 were scheduled for routine screening in the medical
department of the detention center. During the visit, inmates were offered HIV testing
and asked if they were willing to participate in a study regarding benefits and barriers to
HIV testing. The inmates were assured that the HIV testing was voluntary and that it was
being offered to all inmates admitted to MDC-LA. Inmates were invited to complete the
study questionnaire whether or not they opted to be tested for HIV. If the inmate agreed
to participate in the study, verbal as well as written informed consent for participation in
the study was obtained by the researcher and/or medical staff conducting the visit. A
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questionnaire was provided and completed through self-administration or interview
depending on inmate preference. Given the large number of Spanish speaking inmates,
the short survey was also available in a certified Spanish translated version, which was
utilized by 87 Spanish speaking only inmates. Upon completion of the questionnaire,
inmates were provided with a copy of an educational handout (Appendix I) regarding
HIV. If the inmate then also consented to HIV testing, it was ordered and blood was
drawn within 5 business days of intake. Prior to collection of the blood sample for
testing, consent for the blood draw was given by signing the BOP HIV Counseling
Documentation (Appendix J). In addition, inmates agreeing to test received additional
HIV pre-test counseling by the researcher. If the inmate did not consent to participate in
the study but wanted to be tested for HIV, they were referred to the Infectious Disease
Coordinator for follow-up HIV testing and counseling.
The HIV test results were available within a week of testing. Once the results
were available, the inmates received HIV post-test counseling within 2 weeks by the
Infectious Disease Coordinator. In addition, they were provided with an educational
post-test counseling handout, HIV Post-Test Counseling Negative (Appendix K) or HIV
Post-Test Counseling Positive (Appendix L). All inmates with a positive HIV test result
were referred to a physician for further evaluation in accordance with BOP guidelines. In
addition, inmates who tested positive for the virus were referred to the Psychology
Department at MDC-LA for evaluation and counseling.
Study participants’ HIV test results were linked to the survey to allow for
statistical analysis of the proposed research questions. In the prison setting, the potential
exists for patient confidentiality to be either minimal or non-existent due to staff or other
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inmates having access to their personal belongings. Therefore, to eliminate the potential
for a violation of confidentiality and to protect the inmates from other inmates or staff
from seeing the positive results, copies of HIV results were not released to the inmate
while in custody as per current BOP policy. The inmates were informed that they could
request a copy of the results to be mailed to their homes upon a written request to the
Medical Records Department.
If the inmate was released or transferred from MDC-LA prior to receiving the
results of their HIV test, it was scanned into their electronic medical record. Inmates
were informed that if they transferred to another BOP facility, they would receive their
HIV results at the receiving institution. If they were released from the BOP to another
agency or home before results were available, they could request results by writing to the
BOP’s Office of General Counsel. This information was explained to the inmate when
they consented to be in the study. If the HIV test results were positive, it was reported to
Los Angeles County Public Health Department according to California state laws and
regulations. No new HIV positive inmates were released to the community from the
detention center during this reporting period.
D. Measures
1. Dependent Variable
The dependent variable for this study is HIV testing (yes or no) and if
testing rates differed in low-risk versus high-risk sentenced and unsentenced inmates. If
the inmate agreed to voluntary HIV testing, they provided written consent and blood was
drawn for the test. A secondary outcome variable is sero-status for those tested.
2. Independent Variables
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The independent variables for the study include demographic variables
such as gender, age, relationship status (categorical list), ethnicity (categorical list),
highest level of education completed (in years), and HIV risk status (low-risk versus
high-risk). Variables were assessed that under current regulations would have placed the
respondent into the “offered testing” category. Descriptive variables of HIV risk
behaviors were collected, including the number of male and female sexual partners in the
past 5 years (categorical), and the frequency of condom use (categorical list) in general
and at last sexual encounter, as well as tattooing history.
An inmate’s perception of his susceptibility to the virus, its severity and the
benefits and barriers to HIV testing were measured utilizing multiple items that measured
the variable. These dimensions of the HBM were assessed on a 5-point Likert-type scale
(strongly agree to strongly disagree). Examples of the types of questions include: (1) I
believe that HIV infection is very serious and (2) I want to know if I have HIV in order
not to infect someone else. The responses vary from strongly agree to strongly disagree.
Perceived benefits and barriers were measured utilizing a checklist. Some of the barriers
listed include lack of confidentiality, fear of knowing status, stigma, and discrimination,
etc. Some of the benefits listed include early identification of HIV to allow for early
treatment, to find out one’s status, etc.
E. Data Analysis
1. Phase 1 - Qualitative:
The interviews were transcribed and analyzed using a systematic coding
approach informed by Grounded Theory methods. The information obtained was used to
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develop a more responsive questionnaire and to better understand the context of inmate
decision-making regarding HIV testing.
2. Phase 2 - Quantitative:
Prior to the quantitative data analysis, all inmates’ identifying information
was removed to ensure confidentiality and an ID number was assigned to the data that
allowed us to link the survey data to the HIV test results while maintaining
confidentiality. Only the primary researcher had access to identifying and linking
information. All data was verified for accuracy. Any data not de-identified was stored
electronically in password-protected and encrypted files.
A statistician utilizing Version 22 of the Statistical Package for the Social
Sciences (SPSS) software conducted all statistical analyses (IBM Corporation, 2013).
Please see the table outlining the statistical method that was used with each research
question in Appendix N.
F. Power Analysis
To explore our research questions, we utilized descriptive statistics, odds ratio,
chi-square, multivariable logistic regression, independent sample t-test, and multiple
linear regression. PASS Power and Sample Size Calculation was used to calculate the
sample size. A logistic regression of a binary response variable (HIV - yes/no) on a
binary independent variable (low/high risk) with a sample size of 865 observations (of
which 25% were categorized as low risk and 75% as high risk) was set as a target to
achieve 80% power at a 0.050 significance level to detect a change in probability (HIV
positive) from the baseline value of 0.02 to 0.07. This change corresponds to an odds
ratio of 3.688. The method of analysis was adjusted since a multiple regression of the
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independent variable of interest on the other covariate variables in the logistic regression
obtained an R-squared of 0.10.
G. Strengths and Limitations
The current study contributed to the limited existing literature regarding HIV
testing in federal prison settings, also provided data to inform policy changes regarding
HIV testing in the federal prison system. In addition, information about inmates’
thoughts regarding testing and their perceptions about HIV severity, susceptibility, and
benefits and barriers to HIV testing were identified, which we hope will assist detention
center medical staff to better serve the inmates, which may lead to more testing and its
associated benefits.
The setting (only one of many federal detention centers), the cross sectional study
design, and few resources created some limitations of the study. In any cross-sectional
study design, determination of causality is impossible and any conclusions are limited to
the associations observed. However, the mixed method design helped provide some
contextual thoughts about this issue, which somewhat helped to address this limitation.
Also, while not all inmates decided to test, the self-report data and cross sectional
limitations were somewhat addressed by the HIV test results which were explored
through self-report. Another limitation of the study was the short stay of pretrial inmates.
Although researchers contacted pre-trial inmates as soon as possible upon intake, some
inmates may have been released prior to being offered testing. Since the study
participants represent a convenience sample of male inmates at the participating urban
federal detention center, selection and sample bias are additional limitations of the study.
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Hence, the results of the study have limited generalizability and are specific to inmates in
the participating facility.
H. Research Ethics
We are very aware of the sensitive and vulnerable nature of prisoners as a study
population; therefore, steps were taken to assure non-coercion and fully informed consent
for each of the study procedures. Subjects appeared able to freely choose to complete the
questionnaire without testing for HIV, or test for the virus but not complete the
questionnaire. The study adhered to the Belmont Report (1979) principles of respect for
persons, beneficence, and justice. The researcher is also certified by the NIH Office of
Extramural Research on Protection Human Research Participants. The researcher
received approval for the study from the Institutional Review Boards of Loma Linda
University and the Federal Bureau of Prisons before commencing the study. Subject
participation was voluntary and the subjects were well informed about the study aims and
their rights as participants. Verbal and written consent was obtained from all
participants.
There were minimal risks associated with the study, consisting of some personal
and sensitive questions on the questionnaire as well as during counseling. All inmates
entering the jail were offered the opportunity to participate in the study, and there were
no incentives offered to participate. All inmates were given an educational handout on
HIV and the importance of testing.
Confidentiality and security of participating inmates’ personal information was
followed and maintained: all inmate identifiers including name, date of birth, and register
numbers was removed to ensure confidentiality. All questionnaires, recordings, and
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measures were coded, and only the primary researcher had access to identifying
information. All data were stored in a locked cabinet, and electronic files were password
protected, encrypted and only accessible by the researcher. Any information obtained in
connection with this study will remain confidential and not be disclosed without consent
or as required by BOP policy. Upon completion of the study, all documents will be
maintained for 1 year. After a year, all documents will be destroyed using a cross cutter
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Benefits and Barriers to HIV Testing in a Population of Federal Detention Inmates
ABSTRACT
Early HIV testing has reduced the rate of new infections and has been shown to
improve the health and life expectancy of those living with HIV. There remain several
high risk populations that are hard to enlist in voluntary community based HIV testing,
including men who have sex with men, as well as men who have sex with women, and
drug users. To address this, many health professionals have argued for intentionalizing
HIV testing in US prisons and jails but many questions regarding implementation
remains. In light of this, we conducted a cross-sectional study with 721 inmates in a
large urban federal prison between 2012 and 2013 who agreed to participate in a
voluntary survey to help us better understand inmate perceptions about testing, including
perceived barriers and benefits of HIV testing, as well as their perceived susceptibility to
and the severity of HIV/AIDS. Bi-variable and multivariate analyses were used to
determine which constructs were associated with an inmate’s decision to participate in
voluntary testing. The results revealed that age, ethnicity, sentencing status, sexual
orientation, and risk status contributed inmates’ willingness to take an HIV test. Findings
from this study will could help guide HIV testing policies for federal prisons, as well as
providing important information about inmates’ decision making about HIV testing.




While treatment options for the human immunodeficiency virus (HIV) and
acquired immune deficiency syndrome (AIDS) have made them chronic conditions, these
diseases continue to be major public health concerns, especially for sub-groups of
individuals who are not reached by screening efforts for early identification and
treatment. Indeed, as stated in the Executive Summary of the National HIV/AIDS
Strategy for the United States (The White House - Executive Order, 2013), one
American is infected with HIV every nine and a half minutes. Currently, there are over 1
million people in the U.S. who are infected with the virus, and it is estimated that among
these at least 1 in 5 (18.1%) are unaware of their HIV status (Centers for Disease Control
& Prevention [CDC], 2013).
In July 2010, the White House released the first comprehensive National
HIV/AIDS Strategy for the United States. The three primary goals for the strategy
include: (a) reducing the number of people who become infected with HIV; (b)
increasing access to care and optimizing health outcomes for people living with HIV; and
(c) reducing HIV-related health disparities (Executive Order - HIV Care Continuum
Initiative, 2013). To reach these goals, the President is calling for broad support from a
variety of entities that include the Federal government, state, tribal and local
governments, faith communities, scientific and medical communities, and educational
institutions to implement multiple strategies.
In the U.S., there are currently about 2 million people incarcerated in either state
or federal prisons. Adding individuals who are either on probation or parole the number
of people connected with the prison system is tripled (Maruschak & Beavers, 2009).
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According to internal prison data, the number of inmates currently housed in federal
prison is approximately 219,000 (Federal Bureau of Prisons Weekly Population Report,
2013,). Many of the individuals entering the prison system have a history of behaviors
such as unprotected sex, multiple sexual partners, intravenous drug (IV) use, tattooing,
etc. which put them at increased risk for HIV/AIDS (Altice, et ah, 2005; Hammett, 2006;
Hellard & Aitken, 2004). Though prohibited, these behaviors continue to occur in prison,
calling for concerted efforts to test these individuals while incarcerated to limit further
spread of the virus (Andrinopoulos, Kerrigan, Figueroa, Reese, & Ellen, 2010;
Maruschak & Beavers, 2009).
According to Bureau of Justice Statistics, in 2010 there were a reported 20,093
inmates, or approximately 1% of the total custody population in state or federal prison,
identified as infected with HIV. Although the rate of HIV/AIDS among inmates in both
state and federal prison has declined from 194 cases per 10,000 in 2001 to 146 per 10,000
in 2010, the rates of AIDS-related deaths in federal prison remained unchanged at 7 in
both 2009 and 2010 (Maruschak, 2012,).
In 2008, the Federal Bureau of Prisons (BOP) adopted CDC recommendations to
include offering voluntary HIV testing to all individuals convicted of a Federal offense
who are sentenced to a period of six months or more. Additional requirements to the
voluntary testing included assessing an inmate’s risk factors and HIV screening to
determine if the inmate has had a recent HIV test, if they are exhibiting signs or
symptoms of HIV, or if they have had a recent exposure to HIV. This screening is
performed during initial entry and then periodically during their incarceration. The BOP
will test an inmate with any of the following risk factors for HIV:
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• Signs/symptoms of acute HIV infection or HIV-related condition
• Pregnancy
• Recent exposure or victim of a sexual assault
• Active tuberculosis (TB) or a positive TB skin test or,
• When otherwise clinically indicated (i.e. risky behavior, sexually
transmitted disease (STDs), exposure-related, etc. (Federal Bureau of
Prisons Clinical Practice Guidelines, 2013).
Using these criteria, in October 2013, internal prison data found approximately
219,017 sentenced inmates in the BOP who would qualify for voluntary HIV testing.
However, the BOP also currently houses both sentenced and pretrial inmates. Since
current guidelines suggest voluntary testing for sentenced inmates only, approximately
11,000 pretrial (unsentenced) inmates in the BOP each year who are not routinely tested
for HIV unless they meet the Clinical Practice Guidelines as one of the self-identified risk
groups. However, some retrospective studies revealed that a significant number of HIV
cases could have been identified if testing had been done during a prior incarceration
(Duffiis, et al., 2009).
As a result there has been much discussion among health care professionals and
administrators about offering voluntary HIV testing to all inmates, whether sentenced or
pre-trial weighing inmate health against the societal benefits and costs of such policies.
Clearly, HIV/AIDS continues to be a serious disease laden with a number of social and
emotional barriers to testing. Many inmates may be afraid of finding out that they are
HIV positive, and avoid getting screened (Sabharwal, et al., 2010); others fear the stigma
or being segregated from the general prison population. Therefore, in addition to the need
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for providers to create an environment that stresses confidentiality and explains the
benefits of HIV testing, it is important to learn more about inmates’ beliefs and attitudes
regarding HIV testing (Zak-Place & Stem, 2004).
The purpose of this study was to use selected constructs of the Health Belief
Model (HBM) to explore the perceptions of high and low risk inmates, both sentenced
and pre-trial, about the severity of HIV and their susceptibility to contracting the disease,
while identifying what they viewed as barriers and benefits to HIV testing. Study
findings will also be helpful in examining if current BOP policy of testing only high risk,
sentenced inmates sufficient to Health Services Administrative staff and the Medical
Director of the BOP.
METHODS
Participants
Participants for this study included male inmates who entered a large urban
federal detention center between August 2012 and June 2013. The inmates enter our
system as self-surrenders or transfers from other facilities (federal and non-federal). A
total of 721 male inmates entered the facility in this period and were invited to participate
in a study regarding HIV testing in federal detention centers. Prior to receiving their
intake physical exam, each of the 721 inmates were offered voluntary HIV testing, and
asked by medical staff if they wanted to participate in the survey. Of these, 396 (55%)
completed the voluntary survey, which took between 10-15 minutes to complete. If an
inmate agreed to testing, they provided written consent and had their blood drawn. All
participation was voluntary; inmates gave verbal as well as written consent for inclusion
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in the study. All study discussions and consent documents were also available in
Spanish.
Measures
The dependent variable for our analyses was the inmate’s decision whether or not
to be tested for HIV (yes or no) after the offer of voluntary testing was made to e all
inmates, whether sentenced or unsentenced (pre-trial). Independent variables included
standard demographics such as age (in 10 year intervals), race/ethnicity (White, African
American, Hispanic, Asian, other); relationship status (single, married, divorced,
widowed, other); education (0-6; 7-12 grade level, some college, college graduate, other);
primary language spoken (English, Spanish, other); incarceration history (first time
offense, parole violation, repeat charge); and sentencing status (unsentenced vs.
sentenced). Participants also completed a brief standard risk (high vs. low) assessment,
based on CDC standards to determine their risk of contracting HIV. Questions included
the number of male and female sexual partners in the past 5 years; frequency of condom
use in general and at last sexual encounter; injection drug use; history of tuberculosis;
sexually transmitted infections; and tattooing history (Centers for Disease Control, 2013).
Constructs from the Health Belief Model (HBM) for perceived susceptibility to
contracting HIV, perceived severity of HIV/AIDS, and perceived benefits and barriers to
HIV testing were measured utilizing multiple items for each dimension. Perceived
susceptibility and severity were assessed on a 5-point Likert-type scale (strongly agree to
strongly disagree) while barriers and benefits were assessed utilizing a checklist.
Cronbach’s alphas on each of the HBM scales were performed to assess their internal
reliability and while low, were still in the acceptable range of 0.61-0.69.
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Statistical Analysis
To allow us to link the survey data to the HIV test results while maintaining
participant confidentiality, an ID number was assigned to the HIV test and the survey.
Only the primary researcher had access to identifying and linking information, and all
data was verified for accuracy. Any information obtained in connection with this study
remains confidential and will not be disclosed without participant consent or as required
by BOP policy.
Statistical analyses performed included descriptive analyses of participants by
sentencing status (pretrial or sentenced), and decision to test for HIV. Using the survey
data, we then explored HBM constructs by testing decision. Finally, we used a standard
model building approach of conducting bi-variable analyses between demographic and
HBM model variables and HIV testing with an inclusion criteria of p<. 1 to select
candidate variables for the logistic regression. Multiple logistic regression analysis was
then used to estimate the effect of the independent variables on the binary outcome
variables (testing for HIV - yes/no) exploring the demographic profiles of inmates who
decided to participate in HIV testing.
Statistical analyses were performed utilizing IBM Version 22 of the Statistical
Package for the Social Sciences (SPSS) software (IBM Corporation, 2013). Alpha was
set at a significance level of 0.05.
RESULTS
The study sample included 721 male inmates housed in the study site, a detention
center in a large urban area. Of the 721, 31% (223) were sentenced and 69% (498) were 
pretrial inmates. In both sentenced and pretrial inmates, 62.6% were between 18-40
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years of age. Three hundred and ninety-seven (55%) inmates completed the questionnaire
that measured perceptions of HIV severity and susceptibility, as well as barriers and
benefits of HIV testing. Of these, 59.4 % identified as Hispanic. In the pretrial
population, 24.7% were single and 22.9 % married. Of the sentenced population, 21.4%
identified as single and 13.4% as married. Compared to the sentenced inmates, the
pretrial inmates were more educated, with 30% of the pretrial population reporting 7-12
years of education compared to 16.5% among the sentenced inmates. The majority of
both pretrial (31.2%) and sentenced (17.1%) inmates reported that this was their first time
in jail or prison (Table 1).
Table 2 describes the outcomes of the offer of HIV testing: who tested positive,
negative or decided to not get tested among pretrial inmates and sentenced inmates by
risk status (high vs. low). Of pretrial inmates deemed high risk, 26% decided not to get
tested, 4.2% tested positive, and 69.8% tested negative. Among low-risk pretrial
inmates, none tested positive, 82.7% tested negative, and 17.3% decided not to test.
Among sentenced high-risk inmates, 62.7% were negative, 2.4% were positive, and
34.9% decided not to be tested. Among low risk sentenced inmates, 66% were negative,
none were positive, and 34% decided not to be tested. Overall, more sentenced inmates
decided not to be tested (34.5% vs. 21.1%), and a slightly higher proportion of pre-trial
inmates vs. sentenced inmates were HIV positive (1.8% vs. 1.4%).
Table 3 illustrates the percentage of inmates who tested for HIV based upon their
demographic and risk behaviors. Age, ethnicity, sentencing status, and sexual orientation
were all significant factors for engaging in voluntary HIV testing. The majority of
inmates who tested for HIV were Hispanics with a mean age between 31-40 years (p
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=0.001). Pretrial inmates accepted voluntary HIV testing more frequently than sentenced
inmates (72.9% vs. 27.1%). In addition, heterosexual inmates were more likely to test for
HIV when compared to inmates who were homosexual, bisexual, or transgender {p
=0.077).
With respect to HBM model variables and voluntary testing, our descriptive
exploration indicates that all constructs were associated with testing in the desired
direction, inmates who felt that they were more susceptible to contracting HIV were more
likely to get tested. Inmates who felt that HIV testing was beneficial were more likely to
be tested (Table 4).
However, results of the logistic regression indicate that despite inclusion of only
variables that were bi-variably associated with the decision to test only perceived benefits
remained significant positive predictors of testing at p<.05. Perceived severity (in the
direction of being more likely to test) approached significance at p=.079 as did sexual
orientation (heterosexuals being more likely to test) p=.083, and being “other” vs.
Caucasian being less likely to test (p=.051).
DISCUSSION
Many individuals who become incarcerated have had limited access to health care
prior to their arrest. When these prisoners, especially male prisoners, enter jail, it is often
their first exposure to health care since childhood (Goldenson & Hennessey, 2009). In
the U.S., people who are incarcerated have higher rates of health problems and chronic
disease compared to the general population (Goldenson & Hennessey, 2009). The prison
population also is disproportionately burdened with infectious diseases, such as HIV
(Spaulding, et al., 2002).
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In 2006, the Centers for Disease Control and Prevention (CDC) recommended
that correctional facilities perform HIV testing as part of a routine medical evaluation for
anyone 13-64 years of age. Clearly, the federal prison system, with many individuals at
higher risk for HIV infection, is in a position to help reduce the number of new HIV
infections by developing, evaluating, and implementing effective preventive strategies
such as early HIV testing and prevention education.
Basu, Smith-Rohrberg, Hanck, & Altice (2005) recommend that HIV testing be
offered to all inmates, both sentenced and those awaiting sentencing (pretrial) regardless
of risk factors. This, they believe, is the best testing strategy in correctional institutions
to detect HIV early enough for control of transmission and improving the health of
seropositive individuals. However, although testing is offered to all sentenced inmates,
current BOP policy only offers HIV testing to pretrial inmates if they meet certain
criteria. In contrast, our study offered HIV testing to all inmates entering the detention
center. As is the standard pattern in this detention center, most of our study participants
were pretrial inmates (69%). In our study, there was significant acceptance of HIV
testing: among all study participants, 75% of those offered, accepted and were tested for
HIV. The rate of HIV testing was higher among pretrial inmates than those already
sentenced: 78.9% of those awaiting sentencing (pretrial) were tested for HIV compared
to 65.5% of sentenced inmates. Incarceration is considered a risk factor for HIV, but we
further stratified the pretrial inmates to determine if there was a difference in the
seropositivity of low-risk versus high-risk pretrial inmates. This is important as it is
standard practice to offer testing only to those who self-report as being high risk
(according to the BOP Clinical Practice Guidelines). The results suggest two issues: first
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pretrial inmates are often not in the detention center long enough to receive a medical
exam and thus are not assessed for HIV risk. In our study, in which we deliberately
approached all new pretrial inmates for medical exams very soon after arrival, the
standard risk assessment identified nine cases of HIV among those who were classified as
high risk (9.2%). Secondly, we learned that the current policy the of offering testing only
to pretrial inmates who were classified as high risk based on self-report was effective,
since the only cases of HIV were identified in this self-defined high risk group; no new
cases were found in the low-risk group. However, our study also revealed that high-risk
inmates are least likely to test for HIV when offered. Therefore, there may be a
population of inmates who are HIV positive but choose not to take a voluntary HIV test.
We should keep in mind that each testing opportunity, even those which end in a negative
test result, implicitly underscores the importance of STI prevention, and is provides
another window in which to answer questions and reinforce safe sex practices.
Perceived susceptibility to HIV, severity of HIV, and the benefits of and barriers
to testing were also explored. We determined that perceived benefits increased the
likelihood of inmates to test for HIV. Providing information about the benefits to HIV
testing such as early detection of the disease, reduced transmission, and prolonging one’s
quality of life reduced barriers to testing and increased testing rates in our study when
compared to previous HIV testing methods (Beckwith et. al, 2010). An inmate’s
understanding of the benefits or the importance of HIV counseling and testing is essential
for early HIV/AIDS detection to facilitate optimal treatment, prevention of
complications, decreasing transmission, and improving outcomes, and most importantly,
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willingness to test. It is important to evaluate inmates’ understanding of the benefits and
to educate them about the benefits before they make a decision whether or not to test.
Although voluntary HIV testing was offered to all inmates, there was a population
of inmates who did not accept testing when offered; sentenced inmates with less than two
years to serve on their sentence were less likely to test for HIV. Additional studies to
further explore the barriers to HIV testing in this population are needed.
Yet another population of inmates who were possibly less likely to test for HIV
was the gay, bisexual, and transgender inmates. These self-identified groups had very
low numbers, but some of the information gained from them is instructive. The barriers
to HIV testing far outweighed the benefits leading to not testing in this group of inmates;
very few of them agreed to test. Some of the barriers for these groups included being
afraid to get an HIV test, seeing HIV as an unbearable stigma, lack of confidentiality, and
how testing positive for HIV would affect their incarceration. Alternatively it is possible
that these individuals may have tested outside of prison and already knew their status.
Several studies have been conducted examining the different barriers to HIV
testing in other correctional settings. Some barriers included fear of being stigmatized or
discriminated against, being segregated from the rest of the jail population, and
stereotyping as a man who has sex with men or an IV drug user, etc. (Lyons, Lindsell,
Fichtenbaum, & Camargo, 2007; Riley & Baah-Odoom, 2010). As seen in our survey,
these same barriers existed in our population of inmates as well. Because these barriers
exist, measures to reduce them should be implemented, and offering routine rapid HIV
testing to all inmates in correctional settings is one way of doing so (Wakeman & Rich,
2010; Spaulding, et al., 2009).
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The rates of HIV infection in our study for sentenced (2.4%) and pretrial inmates
(4.2%) are much higher than the 1.5% seropositivity rates of the state and federal prison
general population (CDC, 2013). However, due to self-selection bias, many inmates,
both sentenced and pretrial, did not test, which could have affected the seropositivity rate
in our study. Although none of the low-risk individuals who agreed to test were found to
be HIV positive, other studies will most likely find a higher seropositivity rate among
low risk inmates.
There are some strengths and limitations to this study. Our study contributed to
the limited existing literature regarding HIV testing in federal prison settings. In
addition, it provided support to the BOP’s current Clinical Practice Guidelines regarding
HIV testing in the federal prison system, and provided another opportunity to educate
inmates on the benefits of HIV testing. One limitation is that the questionnaire was based
on self-reports; therefore, some of the information regarding high-risk behaviors and
history may be inaccurate. In addition, since study participants were chosen from a self-
selected convenience sample of mostly Hispanic male inmates housed at a large urban
federal detention center, selection and sample bias could mean the results are not
generalizable to other settings and populations.
In conclusion, HIV testing in a prison setting represents an important strategy for
early detection of HIV and improving the quality of life for those living with HIV in a
high-risk population. While our study showed that a significant number of inmates are
willing to be tested for HIV when offered, there is still a population of inmates, some of
whom are at higher risk for contracting the virus, that do not normally accept testing
when offered. HIV testing within our prisons and jails is extremely important, not only
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for the individual but also for the public health of our nation. Undiagnosed HIV has an
impact on both the individual and the community they return to after incarceration,
specifically transmission of the virus and linkage to care for seropositive individuals
(Vlahov & Putnam, 2006). Therefore, it is imperative that jails, state prisons, and the
BOP address the barriers to HIV testing, whether administrative or patient centered.
50
ACKNOWLEDGEMENTS
This research study is part of a dissertation work supported by Loma Linda University,
School of Public Health Department of Preventive Care and the Federal Bureau of
Prisons. The authors wish to acknowledge the support of RADM Kendig, Warden L. R.
Thomas, the Metropolitan Detention Center and Federal Bureau of Prisons. We would
also like to acknowledge LCDR Sophia Hsu, who assisted with the collection of data for
this study and Dr. Khaled Bahjri for his help with the data analysis.
51
REFERENCES
Altice, F. L., Marinovich, A., Khoshnood, K., Blankenship, K. M., Springer, S. A., &
Selwyn, P. A. (2005). Correlates of HIV infection among incarcerated women:
Implications for improving detection of HIV infection. J Urban Health, 82(2),
312-326. doi: 10.1093/jurban/jti055
Andrinopoulos, K., Kerrigan, D., Figueroa, J. P., Reese, R., & Ellen, J. M. (2010). HIV
coping self-efficacy: A key to understanding stigma and HIV test acceptance
among incarcerated men in Jamaica. AIDS Care, 22(3), 339-347. doi:
10.1080/09540120903193633
Basu, S., Smith-Rohrberg, D., Hanck, S., & Altice, F. L. (2005). HIV testing in
correctional institutions: Evaluating existing strategies, setting new standards.
AIDS Public Policy Journal 20(1-2), 3-24.
Beckwith, C. G., Liu, T., Bazerman, L. B., DeLong, A. K., Desjardins, S. F., Poshkus, M.
M., & Flanigan, T. P. (2010). HIV risk behavior before and after HIV counseling
and testing in jail: A pilot study. J Acquir Immune Defic Syndr, 53(4), 485-490.
doi: 10.1097/QAI.0b013e3181 c997b 1
Belmont Report: Ethical principles and guidelines for the protection of human subjects
of research. The National Commission for the Protection of Human Subjects of
Biomedical and Behavioral Research, OPPR Reports, April 18, 1979. Retrieved
July 15, 2010 online at httv://ohsr.od.nih.gov/zuidelines/beImont.html
Centers for Disease Control and Prevention. (2013). HIV in the United States: At a
Glance. Retrieved November 7, 2013 from
http://www.cdc.gov/hiv/pdf/statistics basics factsheet.pdf
52
Centers for Disease Control. (2013). Whose at Risk for HIV. Retrieved November 7,
2013 from http://www.cdc.gov/hiv/risk/index.html
Centers for Disease Control. (2013). HIV in a Correctional Setting. Retrieved
November 7, 2013 from http://www.cdc.gov/hiv/risk/other/con~ectional.html
Duffus, W. A., Youmans, E., Stephens, T., Gibson, J. J., Albrecht, H., & Potter, R. H.
(2009). Missed opportunities for early HIV diagnosis in correctional facilities.
AIDS Patient Care STDS, 23(12), 1025-1032. doi: 10.1089/apc.2009.0197
Federal Bureau of Prisons. (2013). Weekly Population Report. Retrieved November 7,
2013 from http://www.bop.gov/news/weeklv report.isp
Federal Bureau of Prisons. (2009). HIV Testing Implementation Guidance for
Correctional Settings. Retrieved July 15, 2010 from BOP database.
Goldenson, J., & Hennessey, M. (2009). Correctional health care must be recognized as
an integral part of the public health sector. Sex Transm Dis, 36(2 Suppl), S3-4.
doi: 10.1097/OLQ.ObO 13 e318195ad6c
Hammett, T. M. (2006). HIV/AIDS and other infectious diseases among correctional
inmates: Transmission, burden, and an appropriate response. Am J Public Health,
96(6), 974-978. doi: 10.2105/ajph.2005.066993
Hellard, M. E., & Aitken, C. K. (2004). HIV in prison: What are the risks and what can
be done? Sex Health, 1(2), 107-113.
IBM Corp. Released 2013. IBM SPSS Statistics For Windows, Version 22.0. Armonk,
NY: IBM Corp.
53
Lyons, M. S., Lindsell, C. J., Fichtenbaum, C. J., & Camargo, C. A., Jr. (2007).
Interpreting and implementing the 2006 CDC recommendations for HIV testing in
health-care settings. Public Health Reports, 722(5), 579-583.
Maruschak, L. (2012). Bureau of Justice Statistics Bulletin. Retrieved July 24, 2013
from http://www.bi s. gov/content/pub/pdt7hivp 10.pdf.
Maruschak, L. and Beavers, R. (2009). Bureau of Justice Statistics Bulletin. Retrieved
September 28, 2011 from http://bis.oip.usdoi.gov/content/pub/pdf/hivn08.pdf.
Riley, G. A., & Baah-Odoom, D. (2010). Do stigma, blame and stereotyping contribute to
unsafe sexual behaviour? A test of claims about the spread of HIV/AIDS arising
from social representation theory and the AIDS risk reduction model. Soc Sci
Med, 77(3), 600-607. doi: 80277-9536(10)00356-4 [pii]
10.1016/j .socscimed.2010.04.026
Sabharwal, C. J., Muse, K. H., Alper, H., Begier, E., McNeill, M., Galeta, G.,... Parvez,
F. (2010). Jail-based providers' perceptions of challenges to routine HIV testing in
New York City i^ih. J Correct Health Care, 7d(4), 310-321. doi:
10.1177/1078345810378842
Spaulding, A., Stephenson, B., Macalino, G., Ruby, W., Clarke, J. G., & Flanigan, T. P.
(2002). Human immunodeficiency virus in correctional facilities: A review. Clin
Infect Dis, 35(3), 305-312. doi: CID011575 [pii] 10.1086/341418
Spaulding, A. C., Arriola, K. R., Hammett, T., Kennedy, S., & Tinsley, M. (2009). Rapid
HIV testing in rapidly released detainees: Next steps. Sex Transm Dis, 36(2
Suppl), S34-36.
54
The White House. (2013). Executive Order - HIV Care Continuum Initiative. Retrieved
November 6, 2013 from http://www.whitehouse.gov/the-press-
office/2013/07/15/executive-order-hiv-care-continuum-initiati ve
Vlahov, D., & Putnam, S. (2006). From corrections to communities as an HIV priority. J
Urban Health, £3(3), 339-348. doi: 10.1007/s 11524-006-9041-x
Wakeman, S. E., & Rich, J. D. (2010). HIV treatment in US prisons. HIV Ther, 4(4), 505-
510.
Zak-Place, J., & Stem, M. (2004). Health belief factors and dispositional optimism as
predictors of STD and HIV preventive behavior. J Am Coll Health, 52(5), 229-
236.
55
Table 4.1. Demographic Profile of Federal Detention Inmate Sample Population
PRETRIAL Inmates SENTENCED Inmates
Weighted % Weighted %n n
Sex (N=721)






























Incarceration Charge (N=397) 
First time in jail 
Parole violator
7 1.0 18 2.5
133 18.4 62 8.6
159 22.1 72 10.0
137 19.0 58 8.0
41 5.6 14 2.0
10 1.4 10 1.4
27 6.8 34 8.6
29 7.3 35 8.8
155 39 81 20.4
7 1.8 7 1.8
12 3.0 10 2.5
98 24.7 85 21.4
91 22.9 53 13.4
14 3.5 13 3.2
2 0.5 3 0.8
25 6.3 13 3.3
24 6.0 16 4.0
118 30.0 66 16.5
66 16.5 55 13.9
14 3.5 15 3.8
12 3.0 10 2.5
104 26.2 104 26.2
111 27.9 52 13.1
15 3.8 11 2.8
124 31.2 68 17.1
31 7.8 62 15.6
New charge (not first time) 75 19.0 37 9.3
Weighted equals percentage of inmates according to demographics
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9 4.2% 56 26.0%
17.3%
21.1%
234 0 0.0% 49











3 2.4% 44 34.9%
34.0%
34.5%
64 0 0.0% 33
143 3 1.4% 77
* Did not test for HIV
57
Table 4.3. Rates of HIV Testing in a Federal Detention Center
Voluntary HIV Testing P-Value
Yes No
Weighted % Weighted %n n


































































Relationship (n=397) 102 81 0.856
74 70
16 11












































2 .9% 7 3.8%
2.7%1 .5% 5
3 1.4% 1 .5%
Number of female 
sexual partners in the 
past five years. 
(n=397)











Number of male 
sexual partners in the 
past five years. 
(n=397)
0 196 154 0.189
1-5 12 5.6% 15 8.2%




10+ 3 1.4% 7








Table 4.4. HBM Constructs and HIV Testing Decisions
Group Statistics
Variable Voluntary HIV Testing N Std. DeviationMean p-value


















Severity Yes 215 0.001
No 182
Benefits Yes 215 <0.001
182No
Barriers Yes 215 0.017
No 182
Table 4.5. Logistic Regression Model of HIV Testing Decision in Federal Sentenced and Unsentenced 
Inmates
95% C.I. for Odds Ratio 
Odds Ratio LowerVariable Slope p-value Upper
Age
African American vs. Caucasians
Hispanics vs. Caucasians
Others vs. Caucasians














-.231 .551 .794 .372
-.029 .926 .971 .523
-.891 .051 .410 .168
.323 .142 1.381 .898
-.034 .879 .967 .625
-.729 .083 .483 .212 1.101




.238 .079 1.269 .973
.404 1.498.025 1.052
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EXECUTIVE SUMMARY
This policy brief summarizes the evidence and recommendations of HIV testing in
federal detention centers. It provides HIV testing guidance to administrators and




The prevalence of HIV and AIDS among inmates incarcerated in state and federal
prisons is a serious public health concern. In 2010, according to the Bureau of Justice
Statistics (BJS), 20,093 inmates in state or federal prison were infected with HIV, an
8.6% decrease from 2008. In 2009, there were 1,590 inmates with HIV/AIDS in federal
prison and in 2010, the number of inmates decreased to 1,578 (Maruschak, 2012). While
there was a slight decrease in the number of incarcerated persons infected with
HIV/AIDS, the rate of AIDS-related deaths for federal inmates remained the same at
seven inmate deaths in both 2009 and 2010 (Maruschak, 2012).
Early voluntary HIV testing for all inmates is a strategy recommended by the
CDC to detect early new cases of HIV for the prevention, control of transmission, and
improving the health of those incarcerated, early voluntary HIV testing is recommended.
Studies (Andrinopoulos, et ah, 2010; Duffus et ah, 2009) have shown that if HIV testing
was not performed during an early incarceration period, several cases of undiagnosed
HIV may have occurred.
Infection with the human immunodeficiency virus (HIV), can lead to the disease
of acquired immune deficiency syndrome (AIDS), which can be deadly if left untreated
or undetected. The risk of transmission is greatly diminished if treatment with antivirals
is started early. HIV is transmitted through high-risk behaviors such as unprotected
sexual intercourse, intravenous drug use, unregulated tattooing, etc. Many individuals
who enter the federal prison system have a history of the very behaviors that put them at
high risk and many continue some of these behaviors although they are officially
forbidden (Altice, et al., 2005). However, in another study Altice et al. (2005) suggest
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that voluntary HIV testing and counseling policies are not effective in all correctional
facilities in reaching high risk groups, which hinder efforts to decrease HIV prevalence.
Thus to reach a broader range of high-risk groups, use of saliva vs. blood tests, rapid
serologic tests, and more routine testing in high risk and prevalence areas, such as federal
detention centers is recommended. The CDC agrees that HIV testing should be offered
soon after entering detention centers to help identify new cases of infection among this
high-risk group (CDC, 2013).
BACKGROUND AND PROBLEM IDENTIFICATION
In 2008, the Federal Bureau of Prisons (BOP) adopted CDC recommendations to
include offering voluntary HIV testing to all individuals convicted of a Federal offense
who are sentenced to a period of six months or more. Additional requirements included
assessing an inmate’s risk factors and HIV screening during initial entry and throughout
their incarceration period. The BOP Clinical Practice Guidelines on HIV and Preventive
Health currently state that voluntary screening for HIV infection is to be offered at intake
or during the initial physical examination, which is to be completed within 14 days of
admission. The BOP also requires that HIV testing be offered to all inmates with any of
the following risk factors identified during the intake assessment:
• Signs/symptoms of acute HIV infection or HIV-related condition
• Pregnancy
• Recent exposure or victim of a sexual assault
• Active tuberculosis (TB) or a positive TB skin test or,
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• When otherwise clinically indicated (i.e. risky behavior, sexually
transmitted disease (STDs), exposure-related, etc. (Federal Bureau of
Prisons Clinical Practice Guidelines, 2013).
However, testing is not offered to the many persons in federal prisons who await
sentencing - a stay that can last from weeks to years.
METHODS
To explore another substantial opportunity for testing in hard to reach, at risk
populations, we conducted a cross-sectional study with 722 male inmates (18-61+ years)
in a large urban Federal Detention Center. All inmates who came into the system between
August 2012 and June 2013 were seen by a health care provider and offered voluntary
HIV testing whether they were sentenced or awaiting trial (See Table 1 for a
demographic profile on study participants). Inmates were also invited to participate in a
sub-study that involved completing a short behavioral survey assessing their attitudes and
thoughts about barriers to and benefits of HIV testing. Of these, 55% (N=397) agreed to
participate in the sub-study. A university and a federal institutional review board
approved all procedures. Our main aim was to determine if more new cases of HIV
would be identified when testing was expanded to include those who would not normally
be offered HIV testing under the current clinical practice guidelines. Health
professionals see every test as an opportunity for inmates to ask questions about HIV and
re-examine their health habits and sexual practices.
RESULTS
Table 2 describes the results of the offer of voluntary testing: which pretrial or
sentenced inmates, whether high risk or low risk, tested positive, negative or decided not
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to be tested. Among high-risk pretrial inmates, 26% decided not to be tested, 4.2% tested
positive, and 69.8% tested negative. Among low-risk pretrial inmates, none tested
positive, 82.7% tested negative, and 17.3% decided not to test. Among high-risk
sentenced inmates, 62.7% tested negative, 2.4% tested positive, and 34.9% decided not to
test. Among low risk sentenced inmates, none were positive, 66% were negative, and
34% decided not to test. Overall more sentenced inmates decided not to test (34.5% vs.
21.1%) and a slightly higher proportion of pre-trial inmates vs. sentenced inmates were
HIV positive (1.8% vs. 1.4%). Interestingly, substantial numbers of high-risk inmates
decided not to test (34% of high risk sentenced and 26% of high risk pretrial inmates).
Thus, while the study did not reveal an increase in seropositivity among the low
risk pretrial inmates (those who would not normally be offered HIV testing), new cases
were found in high-risk pretrial inmates. Though these inmates would be offered HIV
testing if they were at the facility long enough to receive a health screening and its
accompanying behavioral assessment, this is the ideal scenario and a daily reality. . This
seems to be a unique opportunity to reach high-risk men who have not yet been
sentenced, since they accepted the offer of testing at a higher rate than sentenced inmates.
Our study also identified a population of inmates (sentenced and pretrial) who
were less likely to accept testing when offered; sentenced inmates with less than two
years to serve were less likely to test for HIV (27.1%) compared to pretrial inmates
(72.9%) (Table 3a-c). In addition, gay, bisexual, and transgender inmates were less likely
to test for HIV compared to heterosexual inmates.
While HIV testing is encouraged as a preventive strategy for the early
identification of the disease, simply acknowledging the need for more testing is not
66
sufficient. It is also important to understand the potential benefits and barriers to testing
from an inmate’s standpoint in order to develop effective approaches to overcoming these
barriers. In addition to determining an increase in the number of inmates agreeing to test,
our study used a theory driven survey to evaluate the psychosocial constructs important
to understanding inmates’ concerns, readiness, and needs around testing. Perceived
susceptibility to the virus, its severity, and the benefits of and barriers to HIV testing
were examined. Our study results suggest that the perceived benefits of HIV testing
increased the likelihood of inmates to test for HIV. It also identified several self-
reported barriers that decreased the likelihood of testing for HIV, including: fear of being
tested for HIV; fear that testing positive would create an unbearable stigma; worries
about lack of confidentiality. Some inmates reported having a concern about how a
positive HIV status would affect their psychosocial relationship with both inmates and
staff.
STRATEGIES TO IMPROVE HIV TESTING IN FEDERAL DETENTION
CENTERS
Many individuals who enter the prison system have had limited access to health
care prior to their arrest. This may have been due to homelessness, lack of insurance, or
prevention or medical care being seen as a lesser priority. In addition, since many
voluntary outreach prevention efforts are tied to often stigmatizing or illegal high-risk
behaviors, men may be reluctant to participate. When these prisoners enter jail, it is often
their first introduction to the health care system since childhood (Goldenson &
Hennessey, 2009).
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This makes it possible for prison systems to diagnose, treat, manage, and prevent
the spread of multiple preventable and infectious diseases such as HIV and creates an
opportunity to improve the health of the nation as a whole. If the opportunity to provide
health care and HIV testing is missed in the correctional system, these cases then re-enter
the community (Shiraldi as cited in Rapposelli et ah, 2002) and possibly add to incidence
of the disease.
Traditionally, correctional institutions tend to concentrate HIV testing on
prisoners with high-risk behavior. As a result, more than one in three prisoners are never
tested (Wakeman & Rich, 2010). Routine, voluntary HIV testing for all inmates who
enter federal detention centers is recommended. As seen in our study, the demographics
and risky behaviors are the same in both the pre-trial and sentenced inmates. The BOP
has the opportunity to take the first step in providing care, initiating treatment, and
possibly preventing future cases of HIV if testing is performed and an early diagnosis
provided. Our study revealed that more HIV tests were performed when offered to all
prisoners, both sentenced and pretrial, during medical intake screening upon entry into
the detention center, compared to previous testing methods, which allowed for testing
only according to the clinical practice guidelines. Without baseline data to show the
testing rates prior to this study, the nearly 75% testing acceptance rate represents a
positive outcome. Although testing rates increased with this routine voluntary method,
there are other recommended methods to increase testing in correctional facilities.
When a prisoner enters the correctional environment, they are faced with several
barriers to HIV testing. The model we used to explore prisoners’ attitudes and beliefs
about testing showed that their assessment of the perceived benefits and barriers to
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testing influenced their decision-making. In other words, if the inmate focused on the
benefits, the more likely he was to be tested. However, if the inmates perceived that
there were more barriers, they were less likely to test. As revealed in our study, benefits
increased the likelihood of HIV testing and barriers decreased the likelihood of testing.
Measures need to be implemented to increase inmates’ perceptions of the benefits and
decrease their perceptions of the barriers to HIV testing. Offering routine voluntary HIV
testing to all inmates in correctional settings and educating inmates are two methods to
reduce the barriers of HIV testing and counseling.
CONCLUSION
Inmate contact with the prison health care system provides a unique opportunity
for clinicians to offer HIV testing to a high risk, hard to reach population. HIV testing
within our prisons and jails is important, since undiagnosed HIV affects both the
individual and the community they return to after incarceration.
It is estimated that approximately 60% of pretrial inmates in the BOP are not
routinely offered voluntary HIV testing unless they meet the criteria as stated in the
BOP’s Clinical Practice Guidelines. One of the 2020 Healthy People Objectives is to
increase the proportion of adults who have been tested for HIV in the past year. Our
study aims to addresses this need in a particularly vulnerable and high-risk population,
thus helping to reduce the burden of the disease among federally incarcerated inmates.
A review of the literature on HIV testing revealed that the Federal Bureau of
Prisons has not conducted research regarding strategies to prevent and reduce HIV among
inmates. With an environment different than those of most studies i.e. state and county
jails, there is a need for the BOP to conduct studies about the feasibility and need for HIV
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testing among those incarcerated in the federal system. Our study provided important
information to help BOP administration re-evaluate current policies and guidelines, as
well as explore the perceived benefits and barriers to HIV testing for HIV positive
inmates housed at the Federal Detention Center, where the research was conducted. We
found that several sub-groups of high-risk men - gays, bisexuals, and transgender - were
less likely to seek voluntary testing. Knowing that these groups are less likely to test and
understanding prisoners’ viewpoints on the perceived barriers to and benefits of testing,
physicians, physician assistants, nurse practitioners, nurses, and health care
administrators can gain important insights and awareness about the complexity of issues
faced by prisoners when deciding to accept voluntary HIV testing. This knowledge could
prove useful in shaping recommendations to increase voluntary HIV testing in a high-risk
population in need of early intervention. Furthermore, for those inmates who test sero­
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Table 5.1. Demographic Profile of Federal Detention Inmate Sample Population
PRETRIAL Inmates SENTENCED Inmates
































Incarceration charge (N=397) 
First time in jail 
Parole violator 
New charge (not first time)
498 69.0 223 31.0
7 1.0 18 2.5
133 18.4 62 8.6
159 22.1 72 10.0
137 19.0 58 8.0
41 5.6 14 2.0
10 1.4 10 1.4
27 6.8 34 8.6
29 7.3 35 8.8
155 39 81 20.4
7 1.8 7 1.8
12 3.0 10 2.5
98 24.7 85 21.4
91 22.9 53 13.4
14 3.5 13 3.2
2 0.5 3 0.8
25 6.3 13 3.3
24 6.0 16 4.0
118 30.0 66 16.5
66 16.5 55 13.9
14 3.5 15 3.8
12 3.0 10 2.5
104 26.2 104 26.2
111 27.9 52 13.1
15 3.8 11 2.8
124 31.2 68 17.1
31 7.8 62 15.6
75 19.0 37 9.3
75












9 4.2% 56 26.0%
17.3%
21.1%
234 0 0.0% 49











3 2.4% 44 34.9%
34.0%
34.5%
64 0 0.0% 33
143 3 1.4% 77
* Did not test for HIV








0.527No 100 82 45.1%
p<0.05












Table 5.3c. Rates of Voluntary HIV Testing According to Sexual Orientation in a Federal Detention 
Center (n=397) _________________________________________________
Voluntary HIV Testing P-Value
Yes No






204 94.9% 163 89.6% 0.077
2.3%5 6 3.3%
2 .9% 7 3.8%
1 .5% 5 2.7%




OTHER FINDINGS, CONCLUSIONS, AND RECOMMENDATIONS
One purpose of our study was to identify inmates who are HIV positive; more
specifically, we sought to determine if there was a difference in seropositivity rates
among high-risk versus low-risk sentenced and pretrial inmates, to determine if current
BOP policy of targeted testing is sufficient in identifying HIV positive patients. While
our study identified 4.2% (9) high-risk pretrial inmates and 2.4 % (3) high-risk sentenced
inmates who were positive for HIV, all self-reported a high risk behavior or prior HIV
positive testing history. However, we did not further explore their HIV history to
determine how long they had been diagnosed and if they were diagnosed in a jail or
community setting. This information may have provided additional validity to the study,
emphasizing the importance of HIV testing in jails.
Our study also discovered that among pretrial inmates, 26% of those who were
considered high-risk and 17.3% of those who were considered low-risk did not test for
HIV. Among the sentenced inmates, 34.9% of high risk and 34% low risk did not test.
Overall, there were more sentenced inmates (34.5% vs. 21.1%) who did not test when
compared to the pretrial inmates. Further examining why the inmate did not want to test
may also have provided more insight to the study. However, this is outside of the scope
of our study. Several of the sentenced inmates had been transferred from other BOP
institutions, finishing up their sentences and preparing to re-enter the community. It is
possible that these inmates may have tested at their previous facility and not have felt it
necessary to re-test. On the other hand, pretrial inmates are entering the detention center
from the community or other agencies and may have recently tested for HIV. Both of
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these situations were revealed during the data collection phase, however, this information
was not collected and therefore could not be explored.
As discussed earlier, since the detention center is a short stay facility, it is
important to offer HIV testing when the inmate first arrives to the facility. If the inmate
leaves before testing results are available, BOP policy requires that results will be
forwarded to the facility where the inmate is being transferred. Most importantly, if the
inmate tests positive, the result will be reported to the Public Health Department and
every effort will be made to notify the inmate to ensure continuity of care. During the
study, there was an inmate who upon intake screening revealed that he was HIV positive.
Further investigation revealed that the inmate was at the detention center 4 months prior
to this incarceration however; he was not tested for HIV during his first incarceration at
the detention center. Had he been tested the first time he entered the facility, his HIV
status would have been identified earlier and treatment would not have been delayed.
A. Strengths & Limitations
There are several strengths and limitations to this study. Our study contributed to
the limited existing literature regarding HIV testing in the federal prison system. . In
addition, it provided support to the BOP’s current Clinical Practice Guidelines regarding
HIV testing in the federal prison system. The importance of educating inmates about the
benefits of HIV testing to increase testing rates was identified as another strength of the
study. Another strength was that the primary researcher was able to collect the majority
of the data. While this took longer than anticipated, it ensured that the data collection
was accurate and unbiased, and contributed to the generalizability of the data.
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One limitation of the study involved the questionnaire. Since it was self-
administered and based on self-reports, some of the information regarding high-risk
behaviors and history may be inaccurate, especially given the setting. Another limitation
of the study was the short stay of pretrial inmates; some inmates were released prior to
being offered testing, receiving testing, or receiving their test results. Lastly, with study
participants from a self-selected, convenience sample of male inmates (majority
Hispanic) at a large urban Federal Detention Center, selection and sample bias are
additional study limitations. Hence, the results of the study have limited generalizability
outside the Metropolitan Detention Center, which due to its in Southern California
location had a high percentage of Hispanic inmates.
B. Preventive Care
As stated in the National HIV/AIDS Strategy for the United States, HIV testing is
a critical public health need; specifically, increasing the proportion of new HIV infections
diagnosed before they progress to AIDS is a Healthy People 2020 Objective.
Acknowledging the need for more HIV testing in detention centers is necessary but not
sufficient. Not only did our study reveal the rates of HIV seropositivity among low-risk
and high-risk pretrial and sentenced inmates, it also provided HIV testing guidance to
preventive care specialists who provide care to adults in the prison population. Applying
the HBM, we identified inmates’ perceived susceptibility to HIV, severity of the disease,
benefits of and barriers to inmates’ concerns, and inmates’ readiness and needs around
testing. With this information, preventive care specialists involved in inmate health care
delivery will gain important insight into the meaning, fears, and complexity of HIV
testing among the inmates they serve. This information can then be applied to their
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practice by providing recommendations to increase voluntary HIV testing in a high-risk
population in need of early intervention. Furthermore, for those inmates who test
seronegative for HIV, it likely provided a unique opportunity for education and
counseling of risk behaviors, and for behavior change regarding risk behaviors. Finally,
we found several inmates who were HIV seropositive, and will be able to connect them to
much needed care and counseling, both well-known pillars of secondary prevention and
better health outcomes.
C. Conclusions & Recommendations
As previously mentioned, the goals of the National HIV/AIDS Strategy include
reducing new HIV infection, improving health outcomes for people living with HIV, and
reducing HIV-related health disparities. Our study addressed these needs by offering
HIV testing to all in a particularly vulnerable and high-risk population, thus helping to
reduce the burden of the disease among federally incarcerated inmates. We urge that
HIV testing continue to be offered to all inmates as they enter the prison setting. In
addition, we recommend that additional studies be conducted in the Federal Prison
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Dear Dr. Montgomery,
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proposal titled: Routine HIV Testing in Federal Detention Centers: Implications for 
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The Federal Bureau of Prisons and the Health Services Division view evaluation of our 
HIV testing program as a priority for our infection control program. Thus, we 
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APPENDIX B
INFORMED CONSENT FOR KEY INFORMANT QUESTIONNAIRE (STAFF)
STUDY TITLE: BENEFITS AND BARRIERS TO HIV TESTING IN A POPULATION
OF FEDERAL DETENTION INMATES
Dear Participant:
I am a Doctoral candidate in the School of Public Health at Loma Linda University. You 
are invited to participate in a research study to examine HIV testing and some of the 
perceived barriers and benefits to HIV testing in the inmate population of the 
Metropolitan Detention Center- Los Angeles. If you agree to participate, you will be 
asked to complete a brief questionnaire either face to face or via the telephone. The 
questionnaire will take approximately 20 minutes to complete. Please keep in mind that:
• This questionnaire is completely voluntary.
• It is an anonymous questionnaire. Your name and contact information will not be 
linked to your responses.
• You may refuse to participate or discontinue participation without any penalty or 
loss of benefits.
You may be inconvenienced by having to take time out of your scheduled work related 
duties to complete the questionnaire. We recognize that your participation in this 
research study is an investment of your time and we appreciate your willingness to 
participate in our study.
Even though you will not personally benefit from this study, we hope that it will be a 
positive experience that will allow you to provide information, which may improve HIV 
testing guidelines within the Federal Prison system. Your participation will not only help 
us provide guidance for policy changes regarding HIV testing in the Federal Prison 
System, but it will also assist the medical staff in better serving the inmate population.
Should you have any questions about the research and research subjects’ rights, please 
feel free to contact the student researcher, Nicole Knight, Loma Linda University, School 
of Public Health at (213) 485-0439 ext. 5410 or Dr. Susanne Montgomery, Loma Linda 
University, School of Public Health at (909) 558-8745. If you have any concerns about 
the study, please contact the Bureau’s Research Review Board at (202) 307-3198
Thank you for your time
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APPENDIX C
INFORMED CONSENT FOR KEY INFORMANT QUESTIONNAIRE (INMATE)
STUDY TITLE: BENEFITS AND BARRIERS TO HIV TESTING IN A POPULATION
OF FEDERAL DETENTION INMATES
Dear Participant:
I am a Doctoral candidate in the School of Public Health at Loma Linda University. You 
are invited to participate in a research study to examine HIV testing and some of the 
perceived barriers and benefits to HIV testing in the inmate population of the 
Metropolitan Detention Center- Los Angeles. If you agree to participate, you will be 
asked to complete a brief questionnaire that will take approximately 20 minutes to 
complete. Please keep in mind that:
• This questionnaire is completely voluntary.
• It is an anonymous questionnaire. Your name and contact information will not be 
linked to your responses.
• You may refuse to participate or discontinue participation without any penalty or 
loss of benefits.
• Your decision whether or not to participate will not affect your release date, 
parole eligibility, or legal status.
You may be inconvenienced by having to take time out of your scheduled duties to 
complete the questionnaire. We recognize that your participation in this research study is 
an investment of your time and we appreciate your willingness to participate in our study.
Even though you will not personally benefit from this study, we hope that it will be a 
positive experience that will allow you to provide information, which may improve HIV 
testing guidelines within the Federal Prison system. Your participation will not only help 
us provide guidance for policy changes regarding HIV testing in the Federal Prison 
System, but it will also assist the medical staff in better serving the inmate population.
Should you have any questions about the research and research subjects’ rights, please 
submit a request to speak to Nurse Practitioner Knight in the Health Services Department 
or you may write to Susan Montgomery at Loma Linda University School of Public 
Health Nichol Hall Room 1408 Loma Linda, CA 92350. If you have any concerns about 
the study, please contact the Bureau’s Research Review Board at (202) 307-3198
Thank you for your time
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APPENDIX D
INFORMED CONSENT FOR PILOT RESEARCH
FEDERAL BUREAU OF PRISONSU.S. DEPARTMENT OF JUSTICE
STUDY TITLE: BENEFITS AND BARRIERS TO HIV TESTING IN A POPULATION
OF FEDERAL DETENTION INMATES
Researcher: Nicole Knight, Doctoral Candidate, Loma Linda University
INTRODUCTION
I am a Doctoral candidate in the School of Public Health at Loma Linda University. As 
part of my degree requirement, I am conducting a study called “Benefits and Barriers to 
HIV Testing in a Population of Federal Detention Inmates”. The study is evaluating HIV 
testing in a Federal Detention Center. The results of the study will help to provide 
information regarding the rates of HIV testing as well as the rates of HIV positive 
inmates in a Federal Detention Center. In addition, the study will provide information 
regarding some perceived benefits and barriers to HIV testing. I will publish the study as 
part of my college degree requirements.
PROCEDURES
If you agree to be in this pilot study, you will complete a survey with questions about 
your demographics, sexual history, attitudes, beliefs, and knowledge of HIV testing. The 
survey takes approximately 10 minutes to complete.
BENEFITS
You will receive no direct benefit from being in this study, but we hope that it will be a 
positive experience that will allow you to think about aspects of your life that will 
improve your life. It is important that I receive feedback from you to improve the 
questionnaire. The results of the study may help improve future prison guidelines in 
regards to HIV testing.
RISKS OR DISCOMFORTS
I am not aware of any risks caused from being in this study. You may experience some 
emotional discomforts from answering some of the questions. Personal information 
about you could be revealed if I do not properly protect the data.
STEPS TAKEN TO ALLEVIATE RISKS OR DISCOMFORTS
Upon completion of the questionnaire, there will be an opportunity to discuss your 
emotional discomforts related to completing the questionnaire. You will be given a study 
ID number. This number will be used on your survey and other research papers instead 
of your name and register number. Please help us make sure you cannot be identified as 
a participant in this study; PLEASE DO NOT write your name or register number on any 
of the following pages.
CONFIDENTIALITY
I will do everything that I can to protect the confidentiality of your personal information.
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All information will be handled in the strictest confidence, and only the researcher 
working on the project will have access to information that is traceable to you. All 
materials related to the study will be kept in a locked cabinet accessible only by the 
primary investigator. Your data will be used for research purposes only, and you will not 
be individually identified in any reports or publications. The only exception to this 
policy of confidentiality is information about intent to commit a future crime or to hurt 
yourself or someone else.
RIGHT TO REFUSE OR WITHDRAWAL
Your participation in this study is voluntary, and you may refuse to participate at any 
time without penalty. Your decision whether or not to participate will not affect your 
release date, parole eligibility, or legal status.
CONTACT INFORMATION
If you have any questions about the study please submit a request to speak to Nurse 
Practitioner Knight in the Health Services Department or you may write to Susan 
Montgomery at Loma Linda University School of Public Health Nichol Hall Room 1408 
Loma Linda, CA 92350. If you have concerns about the study, please contact the 
Bureau’s Research Review Board at (202) 307-3198. You may have a copy of this form 
if you would like.
PARTICIPANT’S AGREEMENT
I have read the above information (or it has been read aloud to me). The study has been 
explained to me. My questions have been answered. I voluntarily agree to be in this 
study.
Name (print) Register #
Signature Date
I give the researcher permission to review my Medical file for the reason described in this 
consent form.
Name (print) Register #
Signature Date
WITNESS’ STATEMENT: The information in this consent form was accurately 
conveyed to the participant.
Witness’ Name (print) Signature
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APPENDIX E
INFORMED CONSENT FOR RESEARCH
U.S. DEPARTMENT OF JUSTICE FEDERAL BUREAU OF PRISONS
STUDY TITLE: BENEFITS AND BARRIERS TO HIV TESTING IN A POPULATION
OF FEDERAL DETENTION INMATES
Researcher: Nicole Knight, Doctoral Candidate, Loma Linda University
INTRODUCTION
I am a Doctoral candidate in the School of Public Health at Loma Linda University. As 
part of my degree requirement, I am conducting a study called “Benefits and Barriers to 
HIV Testing in a Population of Federal Detention Inmates”. The study is evaluating HIV 
testing in a Federal Detention Center. The results of the study will help to provide 
information regarding the rates of HIV testing as well as the rates of HIV positive 
inmates in a Federal Detention Center. In addition, the study will provide information 
regarding some perceived benefits and barriers to HIV testing. I will publish the study as 
part of my college degree requirements.
PROCEDURES
If you agree to be in the study, you will complete a survey with questions about your 
demographics, sexual history, attitudes, beliefs, and knowledge of HIV testing. The 
survey takes approximately 10 minutes to complete. In addition, you will be offered HIV 
testing, if you agree to be tested, you will be scheduled to have your blood drawn within 
5 working days in the Health Services Department.
BENEFITS
You will receive no direct benefit from being in this study, but we hope that it will be a 
positive experience that will allow you to think about aspects of your life that will 
improve your life. The results of the study may help improve future prison guidelines in 
regards to HIV testing. It is important that we have as many people participate as 
possible so that our information is as accurate as possible.
RISKS OR DISCOMFORTS
I am not aware of any risks caused from being in this study. There is a small chance that 
you may experience some emotional discomforts such as anxiety about having your 
blood drawn or the results of your HIV test. A referral to Psychology will be done if 
necessary. There is also a minimal risk that personal information about you or your test 
results could be revealed if I do not properly protect the data. However, I will be taking 
EXTRA measures such as removing your name and register number to ensure that your 
personal information is not revealed unless it is required by law. The law requires the 
reporting of HIV positive test results to the Los Angeles County Department of Public 
Health to ensure that you receive proper medical care.
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STEPS TAKEN TO ALLEVIATE RISKS OR DISCOMFORTS
You will receive pre- and post- HIV test counseling by a health care provider. The 
counseling session will provide information about HIV as well as provide an opportunity 
to discuss your emotional discomforts related to HIV testing.
You will be given a study ID number. This number will be used on your survey and 
other research papers instead of your name and register number. Please help us make 
sure you cannot be identified as a participant in this study; PLEASE DO NOT write your 
name or register number on any of the following pages.
CONFIDENTIALITY
I will do everything that I can to protect the confidentiality of your personal information. 
All information will be handled in the strictest confidence, and only the researcher 
working on the project will have access to information that is traceable to you. All 
materials related to the study will be kept in a locked cabinet accessible only by the 
primary investigator. Your data will be used for research purposes only, and you will not 
be individually identified in any reports or publications. The only exception to this 
policy of confidentiality is information about intent to commit a future crime or to hurt 
yourself or someone else as well as reporting as required by law of health care providers. 
All materials related to the study will be maintained for 1 year after completion of the 
study. After 1 year, the documents will be destroyed using a cross cutter shredder.
RIGHT TO REFUSE OR WITHDRAWAL
Your participation in this study is voluntary, and you may refuse to participate at any 
time without penalty. Your decision whether or not to participate will not affect your 
release date, parole eligibility, or legal status.
CONTACT INFORMATION
If you have any questions about the study please submit a request to speak to Nurse 
Practitioner Knight in the Health Services Department or you may write to Susan 
Montgomery at Loma Linda University School of Public Health Nichol Hall Room 1408 
Loma Linda, CA 92350. If you have concerns about the study, please contact the 
Bureau’s Research Review Board at (202) 307-3198. You may have a copy of this form 
if you would like.
COPY OF TEST RESULTS 
BOP CUSTODY
Per BOP policy, we are unable to provide you a copy of HIV results while incarcerated in 
the BOP. If you would like a copy of you HIV test results, you can submit a request to 
medical records with the specific request along with a copy of the address where you 
would like the results to be sent.
RELEASED FROM BOP CUSTODY




Office of General Counsel, Room 841 
Federal Bureau of Prisons 
320 First Street, N.W.
Washington, DC 20534
The request must specifically describe the records being sought and provide 
identifying data, such as date of birth and register number, if known. Also, to ensure that 
private information is not released to anyone else, the requester must verify his/her 
identity either by a notarized original signature or by submitting an original signed Form 
DOJ-361, Certification of Identity.
PARTICIPANT’S AGREEMENT
I have read the above information (or it has been read aloud to me). The study has been 
explained to me. My questions have been answered. I voluntarily agree to be in this 
study.
Name (print) Register #
Signature Date
I give the researcher permission to review my Medical file for the reason described in this 
consent form.
Name (print) Register #
Signature Date
WITNESS’ STATEMENT: The information in this consent form was accurately 
conveyed to the participant.
Witness’ Name (print) Signature
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APPENDIX F











3. Indicate your discipline 
Physician





4. How many years have you been practicing?
5. How many years have you been practicing in a correctional setting?
Please indicate whether you agree or disagree with the following statements. Select 





6. All inmates should be 
offered HIV testing upon 
intake?
7. Only inmates with a history 
of high risk behaviors should 
be offered HIV testing __
8. Offering HIV testing to all 
inmates upon intake will take 
too much time and will interfere 
with my job duties _____
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9. What do you think are some barriers to HIV testing in the inmate population?
10. What do you think are some benefits to HIV testing in the inmate population?
11. Do you have any suggestions for improving HIV testing in the inmate population?
Thank you very much for your participation
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APPENDIX G











3. Indicate your sentencing status
__________S entenced
_________ Unsentenced (Pretrial)
4. How many times have you been to jail?
5. How many years have you been in jail?
Please indicate whether you agree or disagree with the following statements. Select 





6. All inmates should be 
offered HIV testing upon 
intake?
7. Only inmates with a history 
of high risk behaviors should 
be offered HIV testing
8. Offering HIV testing to all 
inmates upon intake will take 
too much time and will interfere 
with my job duties __
9. What do you think are some barriers to HIV testing in the inmate population?
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10. What do you think are some benefits to HIV testing in the inmate population?
11. Do you have any suggestions for improving HIV testing in the inmate population?





Thank you for participating in this research study to share your thoughts and beliefs about 
issues related to HIV testing. Please complete the questionnaire below, answering each 
question honestly and to the best of your ability. Your answers will provide useful 
information about HIV testing in the prison setting. Please DO NOT put your name or 




































1. Which of the following describes this incarceration charge?
_________ New Commit (First time in jail/prison)
_________ Parole violator
_________ New charge (Not your first time in jail/prison)
2. Which describes your sentencing status? 
Pre-trial 
Sentenced

























3. Do you have any tattoos? 
Yes
No
4. Have you ever received a tattoo while you were in jail or prison? 
Yes
No
5. Have you ever been diagnosed with (check all that apply) 
HIV
__________Hepatitis B or C
Positive TB test
6. Do you have a history of drug use? 
__________Yes
__________No (skip to Section C)






SECTION C: The following questions are about HIV Testing
1. When was the last time you were tested for HIV?
_____ never tested (Skip to #3)
__________less than a year
__________2-5 years
__________more than 5 years
2. What was the result of you last HIV test? (Skip to #4)
PositiveNegative
3. If you have NOT been tested for HIV, check the MAIN reason why you have not 
been tested.
The chances of you being exposed to HIV is unlikely 
You were afraid to find out if you were HIV positive 
You don’t need to think about HIV because you are healthy 
You don’t like needles
You don’t trust that your results will be confidential 
You believe that your results will affect your incarceration
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Other (please specify)
4. If you have been tested for HIV, check the MAIN reason why you were tested.
______ You just wanted to find out
______ You had sex with a new partner
______ You had unprotected oral, anal, and/or vaginal sex
______ You have/had a partner who was HIV positive
______ Your partner ask you to have the test
______ It was ordered by your medical provider as a result of another illness
____ _ You used needles for illegal drug injection
______ Other (please specify)_____________________________________
5. Do you think that you are at risk for being infected with HIV? 
Yes No
6. How concerned are you about becoming infected with HIV?
______ Very concerned
______ Somewhat concerned
______ Not too concerned
______ Not at all concerned
______ Don’t know/no response
SECTION D: The following questions are about HIV and AIDS
Please select ONE response for each statement.
YES NO DON’T KNOW
AIDS is not a serious disease, it is like 
having a cold
1.
AIDS is a disease which destroys the 
body’s immune system
2.
There is no cure for HIV/AIDS3.
AIDS is caused by a virus4.
You can get HIV from sharing needles5.
6. You can get HIV from having 
unprotected sex
You can get HIV from sharing the 




8. Only men who are gay get HIV
Please indicate whether you agree or disagree with the following statements. Select 
only ONE response for each statement.




9. People like me do 
not get HIV
10. I am healthy so 
I cannot get HIV
11. lam not worried that 
I might become 
infected with HIV
12. I believe that HIV 
infection is very 
serious
13. I believe that HIV 
infection is life 
threatening
14. I am at risk for HIV/AIDS
Please indicate whether you agree or disagree with the following statements. Select 





15. Everyone who enters 
prison should get 
tested for HIV
16. I plan to get HIV 
tested when offered
17. lam confident that 
getting an HIV test 
will reduce the 
transmission of HIV
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18. Taking an HIV test would 
give me a sense of 
security
19. Getting an HIV test before 
sex tells my partner that 
I care about my and her/his 
health
20. If I had HIV, I would 
rather not know about it
21. It is not important to know 
if I have HIV, because fate 
will decide if I live or die
22. I want to know if I have 
HIV, in order not to 
infect someone else
23. lam afraid to get an 
HIV test
24. I prefer HIV testing 
without counseling
25. Counseling before and 
after HIV testing is 
beneficial
26. If I test positive, it is an 
unbearable stigma
27. Lack of confidentiality is 
an issue with HIV testing 
in prisons
28. Lack of access to medical 
treatment in prison if I
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test positive is a barrier to 
HIV testing
29. If I am HIV positive, it 
may affect my 
incarceration
30. In general what are the barriers to HIV testing for you? {Check all that apply)
______ Lack of confidentiality
______ Fear of knowing my status
______ Rejection by family and friends
______ I would be discriminated against
______ Stigma
______ It may prolong the time before I am transferred to another prison
______ It may affect where I am housed while in prison
______ Other (Specify)_________________________
31. In general what are the benefits to HIV testing for you? {Check all that apply) 
______ To find out the results
______ Early identification of HIV allows for early treatment
______ So that those who are HIV positive can be separated from those who are
negative
______ So that those who are HIV positive can request bail in order to receive
treatment outside of prison
______ Treatment prolongs life and protects my partner(s) from getting it
______ Other (Specify)_________________________




U.S. DEPARTMENT OF JUSTICE 
FEDERAL BUREAU OF PRISONS
JUN 10
HIV INFORMATION SHEET
PROVIDE COPY TO INMATE AT PRE-COUNSELING SESSION
This information is to help you understand about the human immunodeficiency virus (HIV), how it's spread, what 
risks increase the chances of becoming infected and, about the test that determines if you are infected.
HIV is found in the blood, semen, vaginal secretions of an infected person. This virus is associated with the 
development of the disease commonly known as the acquired immunodeficiency syndrome (AIDS), which can 
weaken the body's ability to fight off infection, resulting in an increased risk of infection that is life threatening. 
This test determines if you have HIV antibodies in your blood and are infected with HIV. It is not a test for AIDS.
RISK FACTORS THAT MAY INCREASE THE CHANGES OF BECOMING INFECTED
1. Have had sex with a man.
2. Have had sex with a woman.
____ 3. Injected drugs.
4. Have had sexual relations with a person of the opposite sex with any of the following:
intravenous/injection drug use 
bisexual male
person with bleeding disorder (e.g. hemophilia) 
transfusion recipient with documented HIV infection 
transplant recipient with documented HIV infection 







Received clotting factors for bleeding disorder:.5.
Received an organ transplant or had artificial insemination6.
Have worked as health care or laboratory worker with contact with blood or other potentially 
infectious bodily fluids
7.
8. Have a tattoo that was administered in jail or prison.
Some commonly asked questions about testing are listed below:
1) Who will see my test results?
The results of your test are confidential and revealed only on a "need to know" basis, such as to your health care 
provider(s) or the state health department if required by State law. No one else outside of the Bureau of Prisons 
or health department can be given your test results unless you authorize a release of information.
PDF
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2) What are the possible test results?
A negative test result means no HIV antibodies are detected in your blood at this time.
A positive test result means there is an infection with HIV. It does not mean a person has AIDS.
A test can rarely be inconclusive which means it's neither negative or positive. Your provider will discuss the 
need for retesting, should this occur.
3) Could the test results be inaccurate?
Based on the steps processed by the laboratory to confirm the test, the results are considered more than 99% 
accurate. It is highly unlikely that the result is inaccurate.
Inaccurate HIV antibody results are termed false negative or false positive.
A false negative means the test indicates no evidence or infection when the individual is actually infected.
A false positive means the test indicates evidence of infection when the individual is actually not infected. This is 
extremely rare.
4) Why would a false negative occur?
A false negative usually occurs because the test may not detect infection that's in the early stage. This happens 
because the test measures proteins (antibodies) in the blood that develop over weeks to months as the body 
reacts to infection with the virus. Antibodies may be detected as early as a month after infection with HIV, but can 
take up to 6 months to be measurable. Therefore, if a person was recently infected, the HIV antibody test may be 
negative. This is an example of a false negative. If you think you are at risk of being infected or have recently 
engaged in risky activity and your test result is negative, you should discuss the need for retesting with your 
medical provider.
5) Why would a false positive occur?
A false positive can be associated with past injecting drug use, pregnancy, certain blood abnormalities, other 
related-viruses, and even contamination of the blood sample. Although this is very rare, a small chance of this 
occurring still exists. If you are absolutely certain you have none of the risk factors and received positive test 
results, discuss your concerns with your health care provider.
6) What if my results are positive?
If your results are positive, you are infected with HIV. Your doctor will advise you of additional testing and 
recommended treatment options for HIV infection. Remember, a positive result does not mean you have AIDS 
and with current treatments, persons with HIV infection are living longer and healthier lives.
How long do I have to wait for the test results?7)




9) How can I protect myself from HIV infection?
During incarceration:
Abstain from sexual activity with other inmates, do not inject drugs, do not share razors or toothbrushes with other 
inmates, or get a tattoo, and avoid all other high risk behaviors. If you have a history of using illegal drugs or 
have a problem with alcohol abuse, seek advice on drug treatment programs available during incarceration and 
upon release from health care staff, social workers, psychology staff, or drug counselors.
Upon release:
Abstain from sexual activity or have sexual intercourse with only on partner and know whether th or she is infected 
or not. Talk honestly with your sexual partner and if they do not know if they are infected, encourage them to get 
tested. If you do choose to engage in sexual activity, the best current method of prevention is to use a condom or 
"rubber" to prevent contact with your partner's body fluids. This is no absolute protection, since condoms can 
tear. Becoming pregnant or getting a woman pregnant when infected which may pass HIV infection to the unborn 
child. You should seek further advice and HIV education on more specific methods of preventing infection from 
your health care provider or from community AIDS prevention organizations upon release.
Abstain from injecting drugs, which is strongly associated with many health risks including infection with the 
hepatitis B virus, hepatitis C virus, and HIV. Many local health departments and community AIDS prevention 
organizations can refer you to drug treatment programs and other support services in the community.
If you do continue to engage in injection drug use, you should use clean needles whenever possible, and never 
share vour needles or other injection drug use equipment with others. You may reduce your changes of infection 
by rinsing the "works" with a bleach solution but this is not always effective or safe. You should contact a health 
care provider knowledgeable in this area to get specific instructions.
If you have any future questions, discuss them with your health care provider.
PDF 0.061 of AUG 99
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APPENDIX J
HIV COUNSELING DOCUMENTATIONBP-A0489 
JUN 10
U.S. DEPARTMENT OF JUSTICE
CDFRM
FEDERAL BUREAU OF PRISONS
Directions:
Use the following criteria to counsel the patient who is tested for the HIV antibody. Check 
off each item as they are discussed. Write NA beside any item that is inappropriate to the 
situation. The reverse side of this form will be utilized to document seronegative and 
inconclusive test results. File in the patient's record, documenting in progress notes that 
counseling was completed.
Explained in: (circle) English Spanish Other (specific language)
PRE-TEST:
Explain purpose of session.1.
Explain confidentiality.2.
Explain HIV antibody test.3.
What AIDS is 
What the test is 
Test Procedure 
Meaning of test results
Inability of detecting early infection (false negatives) 
Potential need for additional testing 








risk factors/clinical signs: (check all that apply)List4 .
Injecting drug use, sharing drug or tattoo equipment 
Unprotected or multiplex sex partners
Treated for: sexually transmitted infections, hepatitis, or TB 
Clinical s/s: fever or illness of unknown cause, symptoms of AIDS 
opportunistic infections.










Obtain informed consent (when applicable)5.
Risk Reduction Behaviors. Educational material given.6.
Patient Reactions/Comments.7.
Explain how the patient will be notified of the results.8.
The above information has explained to me in a language I can understand.





File in the Medical Record: Section 6.
1
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HIV Post; Counseling Documentation
Seronegative
Explain purpose of session.1.
Review confidentiality.2 .
Test Information3.
Inform patient of negative test result.
Explain purpose of test.
Identify remaining risks.





Explain risk reduction behaviors (high risk)4 .
Discuss follow-up testing (high risk)5.
Give additional education material if requested.6.
Patients Reactions/Level of Understanding/Comments7.
The above information has been explained to me in a language I can understand.
Signature of Inmate Signature of Staff Counselor
Date:
Inconclusive Test: (neither seronegative or seropositive)
Explain purpose of session.1.
Confidentiality review.2 .
Test Information3.
Inform patient of inconclusive test results. 





Explain risk reduction behaviors.4 .
Discus when and how repeat testing will occur.5.
Patients Reaction/Level of Understanding/Comments6.
The above information has been explain to me in a language I can understand.
Signature of Inmate Signature of Staff Counselor
Date:
Prescribed by P6190PDF






HIV POST-TEST COUNSELING (NEGATIVE)
U.S. DEPARTMENT OF JUSTICE 
FEDERAL BUREAU OF PRISONS
This session is to inform you of your recent HIV test results, review how HIV i s transmitted, and discuss how to decrease 
your chances of becoming infected.
Your recent test for evidence of infection with the human immunodeficiency virus (HIV) has been determined to be 
negative. HIV is associated with the disease known as AIDS, and the negative result me ans there is no evidence of HIV 
infection or risk of developing AIDS.
Commonly asked questions are listed below:
1) Even though the test is negative, can I still be positive?
As mentioned in the pre-test handout, there are false negatives. This is generally the case when people have recently 
been infected due to the fact that it takes some time, up to 6 months, for vira I antibodies to be detected.
2) Does this mean I should be retested?
This question should be answered for your individual situation by your health c are-provider. In general, if you have not been 
involved in any high-risk behaviors, and this continues to be the case, there i s little reason to be concerned with developing 
a positive test.
3) What is "high-risk" behavior?
These are behaviors that can result in transmission of HIV from one person to a nother. High-risk activities are listed below:
a) Unsafe sexual activity - Having unprotected sex with a male or female partner who may be infected.
Contact from a work injury - Work-related contact with blood or other contaminated body fluids that were 
taken into your skin, eyes, nose or mouth.
Receiving a blood transfusion or organ transplant - This risk has been dramatically reduced since accurate 
screening tests for HIV infection became available in 1985.
Having sex with partners at risk - Having unprotected sexual contact with male or female partners: (1) who 
are infected or you are uncertain as to whether they are infected, (2) who inject drugs (3) who have 
received a blood transfusion, organ transplant or artificial insemination from a person with documented HIV 
infection.
Sharing equipment - Sharing injecting (IV) needles, tattoo equipment, razors or other items cont aminated 
with an infected person's blood. If the equipment has been in contact with anot her person's blood it can 





4) Can I still become Infected?
Yes, by engaging in any of the "high-risk" behaviors.
5) Can I spread the infection?
Since your test is negative, probably not. However, remember there is a time la pse between infection and the time when 
your test turns positive. This was discussed under the first question. Anyone with a false negative could still spread the 
infection.
1
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APPENDIX L
Directions: Use the following criteria to counsel the patient who has had a pos itive result to the test for the HIV antibody.
File in the patient's record, documenting in progress notes that counseling was completed.
Your recent testing for evidence of infection with the human immunodeficiency v irus (HIV) has returned, and the results are 
positive. This indicates that you are infected with the virus. This virus is associate d with the disease known as AIDS.
Commonly asked questions are listed below :
99
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4) How did I get the HIV infection?
Infection with this virus occurs as a result of engaging in "high-risk" behavio rs.
5) What are "high-risk” behaviors?
These are behaviors that make you more likely to contract infection with the vi rus. High-risk activities are listed below:
a) Having sex with partners at risk - Having unprotected sexual contact with partners: (1) who are infected or you are 
uncertain as to whether they are infected, (2) who inject drugs (3) who have received a blood transfusion, organ transplant 
or artificial insemination from a person with documented HIV infection.
b) Sharing equipment - Sharing injection (IV) needles, tattoo equipment, razors or other items cont aminated with an 
infected person's blood. If the equipment has been in contact with another pers on's blood it can come transferred to your 
body from the equipment.
c) Contact from a work iniurv - Work-related contact with blood or other contaminated body fluids that were taken into 
your skin, eyes, nose or mouth.
d) Receiving a blood transfusion or organ transplant - This risk has been dramatically reduced since accurate 
screening tests for HIV became available in 1985.
6) Can I spread the infection to other people like my sexual partner or my childrei?
Studies have shown that children of AIDS patients are no more at risk for devebping this disease than any one else. 
Basically, the normal activities of daily home life, such as kissing your child ren, using the same eating utensils, sharing the 
same bathroom facilities, etc., are not risk factors for spreading this illness. You can spread infection to your unborn child 
by becoming pregnant or making your female partner pregnant.
You can spread HIV infection through sexual contact with a male or female partner. Discuss with your physician what 
means you may want to use to prevent this spread. The safest prevention is to a bstain from sex. The next best means is to 
use barrier protection during sexual intercourse with a condom or "rubber." Thi s is not a foolproof measure, since condoms 
sometimes tear or leak.
You should strongly consider discussing your HIV infection with anyone with who m you've had unprotected sex or engaged 
in high risk behaviors in the past, so they can take steps to be tested for HIV infection and receive treatment.
To best protect those around you who may come in contact with your blood or bod y fluids, you should refrain from:
a) having any unsafe sexual activity with men or women.
b) having any sexual activity with a man or woman without discussing your HIV infe ction.
c) sharing any needles or injection drug use equipment with others.
d) sharing personal hygiene items with others that may be contaminated with blood such as razors or toothbrushes.




7) What do I do now with respect to medical care?
Your physician will conduct a baseline evaluation and obtain blood tests to det ermine the stage of your infection. He or she 
will then advise you as to what medical treatments are recommended.
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APPENDIX N
RESEARCH QUESTIONS AND STATISTICAL METHOD
Research Question Statistical Method
1. What are rates of HIV Descriptives in the form of number of HIV
testing in the inmate testing and its percentage out of the inmate
population housed in a population housed in a Federal Detention
Federal Detention Center that offers HIV testing to everyone
Center that offers HIV as part of its medial intake procedures.
testing to everyone as
part of its medial intake
procedures?
2. Does the rate of Odds ratio to compare the rate of voluntary
voluntary HIV testing HIV testing (dependent variable is HIV
differ between un­ testing Yes/No) differ between un­
sentenced low risk sentenced (pretrial) low risk inmates and
inmates and unsentenced un-sentenced high-risk inmates.
high-risk inmates? Multivariable logistic regression was used
to assess the effect of the number of male
and female sexual partners in the past 5
years and frequency of condom use as well
as demographic profiles on the odds ratio
before adding the these variables.
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Independent samples t test for quantitative
variables and chi-square test for categorical
variables will be used for the initial
bivariate analysis.
3. What are the perceived Descriptives in the form of mean +/-
severity and standard deviation or median with range
susceptibility of HIV, will be used to summarize perceived
and the perceived severity and susceptibility as well as
benefits and barriers to perceived benefits and barriers to HIV
HIV testing in this testing.
Federal Detention Multiple linear regression will be used to
Center population that is assess the effect of those who are offered
offered HIV testing? the program versus those who are not on
perceived severity and susceptibility of HIV
and the perceived benefits and barriers to
HIV testing in this Federal Detention
Center. Additional variables such as the
number of male and female sexual partners
in the past 5 years and frequency of condom
use as well as demographic profiles will
also be potentially added to the
multivariable regression model.
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4. What are the rates of Descriptives in the form of number of HIV
HIV seropositivity seropositivity and its percentage out of a
among a population of population of inmates housed at a Federal
inmates housed at a Detention Center that is tested for HIV
Federal Detention
Center that is tested for
HIV?
5. Does the rate of HIV Odds ratio will be used to compare the
seropositivity differ seropositivity of unsentenced (pretrial) low-
between unsentenced risk inmates when compared to unsentenced
(pretrial) low-risk high-risk inmates. (Dependent variable is
inmates and unsentenced HIV seropositivity Yes/No) differ in un-
high- risk inmates? sentenced (pretrial) low-risk inmates versus
unsentenced (pretrial) high-risk inmates.
Multivariable logistic regression will be
used to assess the effect of the number of
male and female sexual partners in the past
5 years and frequency of condom use as
well as demographic profiles on the odds
ratio before adding the these variables.
Independent samples t-test for quantitative
variables and chi-square test for categorical
variables will be used for the initial
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bivariate analysis.
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